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Abstract 
The  type  I  interferon  (IFN-α/β)  system  represents  the  first  line  of  defense  against 
influenza A viruses, and is mainly mediated by the interferon regulatory factors 3/7 
(IRF3/7), nuclear factor kappa B (NF-κB) and activator protein 1 (AP-1) transcription 
factors.  Therefore,  the  non-structural  protein  1  (NS1)  of  influenza  A  viruses  has 
intrinsic abilities to disarm the host cell IFN system, and as a consequence is deeply 
connected to influenza virus pathogenicity and virulence. Based on differences in the 
amino acid sequence of the NS1 genes, the influenza A viruses are divided into two 
distinct gene pools, named allele A and B. This division is strictly based on genetic 
characterization, and their functional consequences are largely unknown. 
The results in this thesis provide novel structural and functional insights, indicating 
that allele A NS1 proteins of various avian influenza A viruses have a stronger capacity 
to inhibit the activation of IFN-β production than allele B proteins from corresponding 
subtypes.  This  claim  was  further  confirmed  by  measurement  of  IFN  stimulatory 
response element (ISRE) promoter activation, IFN-β mRNA transcription and IFN-β 
protein expression. Intriguingly, the allele-specific levels of inhibition correlated with 
the nature of the disease, where for example allele A influenza virus appeared to be 
more pathogenic than allele B viruses in minks (Mustela vison). Further investigations 
demonstrated  that  allele  B  NS1  protein  resembles  to  its  IFN  antagonistic  nature  in 
exerting similar effect in preventing double stranded RNA (dsRNA) induced NF-κB 
and AP-1 promoter activation, which subsequently results in an overall inhibition of 
IFN-β production. In an effort to understand the structural basis of IFN inhibition, it 
was  revealed  that  inhibitory  activities  for  ISRE,  NF-κB  and  AP-1  promoters  and 
subsequent inhibition of IFN-β were mapped to the C-terminal effector domain of the 
NS1 protein. 
Genetic characterization of a reassortant H9N2 influenza virus revealed that the virus 
acquired the NS segment from a H5N1 of genotype Z, clade 2.2. Screening the IFN 
antagonist abilities of both NS1 proteins (H5N1 and H9N2) demonstrated a high degree 
of  functional  homology  at  IRF3,  ISRE,  NF-κB  and  AP-1  levels,  which  resulted  in 
strong inhibition of IFN-β production in cell culture system. 
Taken together, these studies expand the information concerning the versatile nature 
of the NS1 protein and highlight its indispensible role in reassortant influenza A virus 
pathogenesis. 
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''Believers, when you are told to make room in a meeting for others, do 
so. Allah will then make room for you. When you are told to disperse, do 
so. Allah will raise the position of the believers and of those who have 
received  knowledge.  Allah  is  well  aware  of  what  you  do''  Al-Quran, 
Sūrah-al-Mujādilah (Chapter 58, Verse 11). 
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1  Introduction 
1.1  Background of avian influenza viruses 
Avian influenza viruses (AIV) have emerged as devastating pathogens not only 
for poultry industries, where they infect millions of birds (over 200 million 
from 1999-2004) but also have human health implications, especially due to 
recent increase in spread of Asian H5N1 viruses (Capua & Alexander, 2008). 
Although wild aquatic birds, such as waterfowl and shorebirds, are primary 
natural hosts for avian influenza viruses, interspecies transmission has been 
recorded (Webster et al., 1992). In wild aquatic birds, influenza viruses usually 
infect  the  lower  intestinal  tract  and  transmit  via  the  fecal-oral  route. 
Intriguingly, the genome of influenza viruses has been detected in at least 105 
avian  species  (Olsen  et  al.,  2006).  However,  among  all  the  subtypes  of 
influenza A viruses, only H1N1, H2N2, H3N2, H5N1, H7N7, H7N2, H7N3 
and  H9N2  have  been  reported  to  cause  illness  in  humans,  as  reviewed  in 
Cheung & Poon (2007). This selective adaptation could be a result of steady 
evolution of AIV to several species of animals, and ultimately terminating in 
human pandemics several times in the last 100 years (Taubenberger & Morens, 
2009) (discussed below in detail). 
The highly pathogenic avian influenza virus (HPAIV) H5N1 is now widely 
prevalent in most of the countries of Southeast Asia, the Middle East, Europe, 
Africa and Asia. Although, transmission of AIVs to humans may require an 
intermediate host such as swine, there are indications of direct transmission of 
H5,  H7  and  H9  to  humans  (Fouchier  et  al.,  2004;  Bridges  et  al.,  2002; 
Cameron et al., 2000). The low pathogenic avian influenza viruses (LPAIV) 
such as H9N2 have shown increased infection levels in recent years, especially 
in the Middle East, Asia and Europe (Capua & Alexander, 2008). Provided that 
H9N2 viruses have potential to infect humans, monitoring of such cases would 
be  of  importance  to  ascertain  their  genetic  variability  and  ability  to  switch   12 
hosts (Capua & Alexander, 2008). Each of the human influenza pandemics 
occurs  with  a  different  approach  and  has  different  characters,  which  are 
primarily contributed by a complex and polygenic mechanism of host-switch 
(Taubenberger  &  Kash,  2010).  This  makes  the  understanding  of  AIV 
replication and transmission complicated. Taken together, future progress is 
required  for  identification  of  the  molecular  mechanisms  of  AIV  host 
adaptation, pathogenesis and multifactorial host-pathogen interactions. 
1.2  Biology of influenza viruses 
1.2.1  Overview 
Influenza  viruses  are  members  of  the  family  Orthomyxoviridae.  The  virus 
particles  are  enveloped,  containing  a  segmented,  single-stranded,  negative-
sense RNA genome (i.e. the genome is complementary to mRNA, which by 
convention is termed positive-sense) (Klenk et al., 2004). The genera in this 
family  include  influenza  A  virus,  influenza  B  virus,  influenza  C  virus, 
thogotovirus and isavirus (infectious salmon anemia virus) (Palese & Shaw, 
2007).  The  three  influenza  viruses  (A,  B  and  C)  differ  in  host  range  and 
pathogenicity. Based on their surface glycoproteins, hemagglutinin (HA) and 
neuraminidase (NA), the influenza A viruses are further subdivided into 16 
subtypes of HA protein (1-16) and 9 subtypes of NA (1-9) protein (Fouchier et 
al.,  2005;  Laver  et  al.,  1984).  Among  144  (16x9)  theoretically  possible 
combination of HA and NA influenza subtypes, at least 116 have been reported 
in birds. However, only the H5 and H7 subtypes are identified as HPAI in 
susceptible bird populations (Webster et al., 1992). 
1.2.2  Structure of influenza virus particles 
The  virions  of  influenza  A  and  B  genera  are  structurally  identical,  but 
influenza C virus particles are more divergent. Influenza A virus particles are 
pleomorphic in shape, which varies from small spherical (80-120 nm) to long 
filamentous (300 nm). Although morphologic characteristics are a genetic trait, 
the viral strain and cell-type used for propagation may significantly determine 
the shape of influenza viruses. The whole virion is composed of 1% RNA, 
70% protein, 20% lipid and 5-8% carbohydrates (reviewed in Lamb & Krug, 
2001). 
The influenza A virions consist of eight single-stranded RNA segments, 
which encode for 11 (or up to 13) viral proteins during infection (reviewed in 
Garcia-Sastre,  2005;  Lamb  &  Krug,  2001)  (Figure  1  A).  Additionally,  a 
putative  open  reading  frame  (ORF)  in  the  positive-sense  of  segment  8  has 
recently  been  identified,  which  encodes  for  a  hypothetical  negative  sense   13 
protein (NSP) of ~25 kDa (Zhirnov et al., 2007). Recently, another protein 
encoded in segment 2 (in addition to PB1 and PB1-F2) has been identified, 
termed N40 (Wise et al., 2009). Morphologically, influenza A virus particles 
are  lined  with  a  layer  of  approximately  500  spikes  (each  of  10-14  nm), 
protruded  from  a  lipid  envelope,  which  is  derived  from  the  host  plasma 
membrane.  These  spikes  appear  as  either  rod-shaped  (HA)  or  mushroom-
shaped (NA) (Figure 1 B). The ratio of HA to NA generally varies from 4:1 to 
5:1.  The  high  density  of  HA  is  probably  to  enhance  the  chances  for  viral 
attachment.  Additionally,  the  matrix  protein  2  (M2)  transverses  the  lipid 
envelope and overlays a matrix of M1 protein. The ratio between M2 and HA 
is usually about 1:10 to 1:100 (Zebedee & Lamb, 1988). The matrix protein 1 
(M1) is the most abundant viral protein and underlies the lipid bilayer, and is 
associated with the vRNP core of the virion to structurally support the particle. 
1.2.3  Viral ribonucleoprotein (vRNP) 
The vRNP is the stable lipid-free core within the virion. The vRNP appears as 
flexible rods in thin sectioning of the virus. Structurally, vRNPs look like a 
twin-stranded helix, in which vRNPs present loops at one end and a bend at 
other. The strand seems to be folded back on itself and then coiled on itself, to 
form a type of twin-stranded helix (Figure 1 C) (reviewed in Lamb & Krug, 
2001). 
 
 
Figure 1. A schematic diagram of the influenza A virus particle and its components. (A) Eight 
gene segments of influenza A virus encode for 11-13 different proteins of variable sizes. (B) An 
influenza virus particle carrying all the structural components. (C) Composition of vRNPs, and a 
key for the influenza virus proteins. 
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Four viral proteins along with the viral RNA constitute the vRNP (Figure 1 C). 
Among these proteins, NP is the predominant protein, and it coats the viral 
RNA  (vRNA).  Associated  with  the  vRNPs  is  the  heterotrimeric  RNA-
dependent  RNA  polymerase  complex,  consisting  of  the  two  “polymerase 
basic” (PB1 and PB2) and one “polymerase acidic” (PA) subunits. These are 
present at only 30 to 60 copies per virion (Lamb & Krug, 2001; Inglis et al., 
1976; Lamb & Choppin, 1976). 
The varied roles of these proteins are briefly outlined below in the context 
of the influenza virus replication cycle, and concisely summarized in Figure 2. 
 
Figure  2.  A  schematic  genome  organization  of  the  influenza  A  virus.  The  complete  RNA 
segments are shown in nucleotides whereas their encoded proteins are presented in amino acids. 
The lines at the 5´and 3´ termini represent the noncoding regions. The PB1 segment contains a 
second ORF in the +1 frame resulting in the PB1-F2 protein. Another ORF encodes for N40, 
which is identical to that of maternal PB1 except for truncated 39 amino acids in the N-terminus, 
is shown in dotted lines. The M2 protein and the nuclear export protein (NEP) are encoded by 
spliced  mRNAs  (the  introns  are  indicated  by  the  V-shaped  lines).  A  putative  ORF  for  a 
hypothetical negative sense protein (NSP) within segment eight is shown.  
1.3  Zoonotic potential and influenza pandemics 
Influenza A viruses have a certain level of host specificity, but breaching host 
species barriers is not uncommon. Therefore, it is critical to understand the 
zoonotic potential of non-human (avian, swine and equine) influenza viruses, 
and to ascertain the contribution of these species in the generation of novel 
variants  that  could  lead  to  future  influenza  pandemics.  It  has  been 
demonstrated that reassortment of genomic fragments, involving those coding 
for glycoproteins (HA and NA), usually results in emergence of new pandemic 
strains  of  influenza  viruses  in  humans.  However,  major  epizootics  have 
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repeatedly been reported from poultry, horses, seals, camels and pigs (Hayden 
& Palese, 1997; Yamnikova et al., 1993). 
Influenza pandemics are global outbreaks of the disease that cause serious 
illness and spread easily from human to human. In the case of influenza, such 
conditions happen when unusual new variants appear from the combination of 
unique HA and NA strains from different viruses, by antigenic drift and shift 
(reassortment) (discussed below). Although, the history of influenza A viruses 
dates  back  to  Ancient  Greek  in  about  413  BC  (Potter,  1988),  the  first 
confirmed  pandemic  was  the  Russian  flu  of  1889-1892  (Potter,  2001; 
Kuszewski  &  Brydak,  2000).  In  the  20
th  century,  a  devastating  pandemic 
(Spanish flu) appeared in 1918 and lasted into 1919 (Figure 3). Since the first 
isolation  of  influenza  A  viruses  in  1933,  it  has  been  speculated  based  on 
serology that the HA protein in this pandemic was of avian origin. Viruses of 
this subtype circulated until the Asian flu in 1957, when a new virus of another 
HA and NA (H2N2) was isolated (reviewed in Webster et al., 1992). It was 
confirmed that H2N2 virions are composed of PB1, NA and HA genes of an 
avian  origin,  and  PB2,  PA,  nucleoprotein (NP),  M  and  non-structural  (NS) 
genes were acquired from previously circulating H1N1 viruses (Scholtissek et 
al., 1978). These viruses circulated for 11 years when a new strain caused a 
new  pandemic  in  1968  with  the  introduction  of  a  novel  HA  variant  (H3). 
Besides  the HA gene, these viruses acquired a PB1 gene segment from an 
avian virus, whereas the rest of the genes were from human influenza viruses 
(Kawaoka et al., 1989; Scholtissek et al., 1978). Although controversial, H1N1 
reemerged in 1976 and were reported as Russian influenza (H1N1) (Dowdle, 
1997). Interestingly, the Asian flu, Hong Kong flu and Russian flu pandemics 
have several factors in common, such as their appearances were sudden, all 
were  first  reported  in  China,  all  were  antigenically  different  from  already 
circulating viruses in human, and belonged to either H1, H2 or H3 (reviewed in 
Webster  et  al.,  1992).  Provided  that  both  pandemics  (1957  and  1968) 
originated by genetic reassortment between avian and human influenza viruses, 
it was concluded that a highly pathogenic avian influenza virus H5N1 evaded 
the host-specific restriction and caused infection to humans in 1997-98. 
After 41 years, in 2009, a swine origin flu hit the human population and 
spread  to  several  countries  around  the  globe  (MacKenzie,  2009).  It  was 
determined that the swine flu virus (H1N1) was a mixture of genes from four 
different  viruses:  North  American  swine  influenza,  North  American  avian 
influenza, human influenza, and Eurasian swine influenza viruses (Figure 3). 
Taken together, these pandemics have originated from close contact among 
humans,  avian  and  swine.  The  magnitude  and  spread  of  these  influenza 
pandemics are determined by environment, socio-economical  behaviors  and   16 
the geographical location of the influenza hot spot (reviewed in Kuiken et al., 
2006).  Therefore,  it  is  crucial  to  understand  the  general  principle  of  these 
factors, which trigger the avian influenza viruses to breach the species barriers. 
 
Figure 3. Evolution of influenza A viruses and their circulation in humans. 
1.4  Molecular determinants of the host range restriction and 
pathogenicity 
The majority of the influenza A viruses are host-specific, but owing to their 
capacity to infect a wide range of animals, this specificity is partial (Webster et 
al., 1992). There is a great wealth of reports providing evidence for occurrence 
of  interspecies  virus  transmission.  Direct  indications  of  the  potential  for 
adaptation  are  the  transmission  of  avian  H1N1  and  human  H3N2  to  swine 
(Scholtissek et al., 1983; Ottis et al., 1982), swine H1N1 to humans (Rota et 
al.,  1989),  an  avian  H3N8  to  equines  (Guo  et  al.,  1992),  avian  influenza 
viruses to seals (Webster et al., 1981), to whales (Hinshaw et al., 1986) and to 
minks (Klingeborn et al., 1985). It has been experimentally proven that avian 
influenza  viruses  cannot  replicate  efficiently  in  humans  nor  do  human 
influenza viruses have the ability to propagate in avian species, despite direct 
and close contact between the two species (reviewed in Ito & Kawaoka, 2000). 
In contrast, there are indications that avian influenza viruses can transmit and 
cause disease in humans in natural infections (Subbarao et al., 1998; Claas et 
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al., 1994). In this complex scenario, and in the context of the recent swine 
influenza  pandemic,  it  is  clear  that  several  viruses  can  readily  evade  host 
restriction barriers. Although, the complete list of factors that determine the 
host  restriction  is  not  fully  illustrated,  there  have  been  significant 
advancements in this respect. 
The hemagglutinin protein, due to its essential role in receptor recognition 
and attachment, is considered to be a primary determinant of host-range. The 
receptor specificity of influenza A viruses depends on its species of isolation 
(Webster et al., 1992). Human seasonal viruses almost exclusively bind to N-
acetylneuraminic (sialic) acid receptors α-2,6 linkage (NeuAc α-2,6), whereas 
avian influenza viruses predominantly bind to NeuAc α-2,3 linkage. Owing to 
having both NeuAc α-2,3 and NeuAc α-2,6 linkages, pigs and several avian 
species (pheasants, turkeys, quails) may act as mixing vessels and can generate 
reassortant viruses (reviewed in Medina & Garcia-Sastre, 2011) (Figure 4). 
 
Figure 4. Factors responsible for influenza A virus host adaptation and pathogenesis.  
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For  efficient  infection  and  replication  of  influenza  A  viruses  in  the  host, 
receptor binding is not enough. There is increasing evidence about the role of 
RNA-dependent RNA polymerase basic subunit 2 (PB2) in the pathogenicity 
of influenza viruses. Interestingly, it has been shown that all human influenza 
A viruses carrying K267 amino acid are highly pathogenic in mice, whereas 
K267G substitutions can determine the low pathogenicity of avian viruses in 
mammalian models (Hatta et al., 2001; Subbarao et al., 1993). Fatal infections 
of HPAI H7N7 and HPAI H5N1 in humans were also associated with K267 
substitution within PB2 (de Wit et al., 2010; Fouchier et al., 2004). Further, it 
has  been  established  that  D701N  substitution  in  PB2  is  crucial  for  the 
adaptation of avian origin viruses to mammalian species (de Jong et al., 2006; 
Gabriel et al., 2005). Interestingly, PB2 protein of the 2009 pandemic H1N1 
lacked both of these substitutions, but it still replicated in mammals. It was 
concluded that another residue at position 591 (R591) could compensate both 
of the previously characterized substitutions (Yamada et al., 2010; Mehle & 
Doudna, 2009). 
Apart from HA and PB2, other components of viral ribonucleoprotein (PA, 
PB1, NP), and internal genes (M2, NS1, NA and PB1-F2) can also play a role 
in host discrimination, and are markedly associated with the pathogenicity and 
virulence of influenza A viruses. The various roles of these proteins in virus 
tropism and pathogenicity are briefly summarized in Figure 4. 
Recently, using genome-wide approaches it has been highlighted that not 
only  viral  elements  but  host  specific  ones  also  contribute  to  successful 
replication and virulence of influenza infection (reviewed in Watanabe et al., 
2010). These factors contribute to all of the steps in influenza viral replication. 
Therefore, these are discussed in the context of viral replication (see below). 
Briefly, it has been demonstrated that cellular V-type proton ATPase subunit D 
1  (ATP6V0D1)  leads  to  decreased  viral  replication  if  silenced  with  small 
interfering RNA (Hao et al., 2008). ATPase ATP6V0D1 mediates the viral 
endocytosis  process.  It  has  further  been  shown  that  a  cellular  protein, 
CAMK2B, also facilitates the replication of influenza A viruses (Karlas et al., 
2010;  Konig  et  al.,  2010).  Recently,  it  has  been  revealed  that  human 
CLE/C14orf166  protein  (hCLE)  interacts  with  the  influenza  A  virus 
polymerase complex. This interaction was found to be important for induced 
viral polymerase activity, viral RNA transcription and replication, virus titer, 
and viral particle production, which in turn results in increased viral replication 
(Rodriguez  et  al.,  2011).  A  molecular  understanding  of  these  cellular 
regulators of influenza infection may help to resolve many concerns of host-
pathogen interactions, and may also help to develop novel therapeutic agents to 
combat this deadly disease (Medina & Garcia-Sastre, 2011).   19 
1.5  Replication of influenza A viruses 
Replication of influenza A viruses is based on the following fundamental steps, 
as illustrated in Figure 5. 
1.5.1  Receptor binding 
The  viral  epical  glycoprotein  HA  binds  to  N-acetylneuraminic  (sialic)  acid 
receptors on the host cell surface (Skehel & Wiley, 2000) (Figure 5). Influenza 
viruses isolated from humans and swine show high affinity to one kind of sialic 
acid  (α-2,6  linkage)  receptors,  whereas  avian  and  equine  viruses  primarily 
recognize sialic acid of another kind (α-2,3 linkage) (Daly et al., 2011). In 
humans, both kind of these receptors exist but α-2,6 linkage is predominant 
(Matrosovich et al., 2004). On the other hand, α-2,3 linkage is more common 
in duck. Pigs are more susceptible to the disease due to having both forms of 
sialic acid receptors (Ito et al., 1998). 
 
Figure 5. Schematic representation of the influenza A virus replication cycle. See text for details. 
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1.5.2  Endocytosis and uncoating 
After binding to receptors, the whole virus particle is transported into the cell 
through receptor-mediated endocytosis in the form of pre-lysosomal, low pH 
vesicles (Whittaker & Digard, 2006). The involvement of host GTPase (Roy et 
al., 2000) and rearrangements of cellular actin (Lakadamyali et al., 2003) are 
essential  to  facilitate  such  internalization.  Two  cellular  kinases  further 
accompany  this  process:  protein  kinase  C  (Sieczkarski  et  al.,  2003)  and 
phosphoinositide 3-kinase (Ehrhardt et al., 2006). 
 
The acidity (pH 4.5-5.5) of the endosomal compartment is crucial for the 
uncoating and subsequent release of viral RNPs, which is completed in two 
steps (Whittaker & Digard, 2006; Lamb & Krug, 2001). The low pH triggers a 
conformational change in the HA protein, and cellular proteases cleave it into 
two  subunits:  HA1  and  HA2.  The  HA2  mediates  the  fusion  of  viral  and 
endosomal membranes. Although essential for viral infectivity, this event alone 
is  insufficient  to  deliver  the  individual  viral  genomic  segments  into  the 
cytoplasm. Therefore, the low pH also triggers the flow of protons into the 
virus  via  M2  ion  channels,  causing  dis-association  of  vRNPs,  which  are 
otherwise attached to M1 (Lamb & Pinto, 2006; Bui et al., 1996). 
1.5.3 Nuclear import of viral RNPs 
Following release, the vRNPs are transported into the nucleus via interaction 
with the cellular importin-α/β (Whittaker & Digard, 2006; O'Neill et al., 1995; 
O'Neill & Palese, 1995), which is mediated by multiple nuclear localization 
signals (NLSs) of the nucleoprotein. Apart from nucleoprotein, all of the other 
components of RNPs also carry the NLSs (Nieto et al., 1992; Mukaigawa & 
Nayak, 1991; Nath & Nayak, 1990). Upon nuclear translocation, the vRNP 
strongly interacts with insoluble “nuclear matrix” or “chromatin components” 
(Whittaker & Digard, 2006; Bui et al., 2000). 
Unlike  most  other  negative  strand  RNA  viruses,  replication  and 
transcription of influenza A viruses occur in the nuclei of the infected cells 
(Jackson  et  al.,  1982;  Herz  et  al.,  1981).  This  is  possibly  due  to  two 
transcriptional requirements: initiation of viral mRNA synthesis requiring the 
capped 5´-ends of host messenger RNAs (mRNAs) to act as primers (Plotch et 
al.,  1981),  and  two  viral  mRNAs  requiring  splicing  (reviewed  in  Lamb  & 
Krug, 2001). However, two other families (Bunyaviridae and Arenaviridae) 
require  5´cap  structures  for  mRNA  transcription,  yet  these  replicate  in  the 
cytoplasm (reviewed in Buchmeier et al., 2001). On the other hand, a member 
of Bornaviridae family (Borna disease virus) requires splicing and therefore 
replicates  in  the  cell  nucleus  (de  la  Torre,  2001).  This  indicates  that  the   21 
replication and transcription of influenza A viruses in the nucleus is most likely 
due to the requirement of splicing. 
1.5.4  Synthesis of viral mRNA 
The viral mRNA synthesis has to occur in the nuclei of the infected cells, and 
requires a full RNP complex: NP, PA, PB1 and PB2 (see Figure 1 C) (Portela 
&  Digard,  2002;  Huang  et  al.,  1990).  Since  influenza  viruses  use  the 
translation machinery of host cells, the mRNA need to be capped [addition of 
7-methylguanylate  (m
7G)  at  the  5´-end]  and  polyadenylated  [addition  of 
poly(A)  tail  at  the  3´-end]  for  efficient  translation  into  protein(s).  For 
polyadenylation, influenza A viruses encode a stretch of 5 to 7 uracils (U) in 
the negative sense vRNA. The viral polymerase transcribes this stretch into 
positive sense as a string of adenosines (A), which make the poly(A) tail of 
mRNA (Robertson, 1979). For capping, the PB2 subunit binds to the 5´cap of 
the host pre-mRNAs and the PB1 subunits of the viral polymerase cleave the 
5´capped primer (m
7GpppXm cap structure of 10-13 nucleotides) from host pol 
II-mRNA transcript (cap snatching) owing to an endonuclease activity (Plotch 
et al., 1981), which acts as a primer to initiate viral mRNA synthesis (reviewed 
in Krug, 1981). 
As a consequence of post-transcriptional modifications, three types of viral 
mRNA translocate to the cytoplasm: (i) six viral mRNAs that lack introns (PA, 
PB1, PB2, NP, HA, NA), (ii) two viral mRNAs that contain introns but non-
spliceable (M1, NS1), and (iii) two mRNAs (M2, NEP) which are generated by 
the splicing of M1 and NS1 mRNAs, respectively (Krug et al., 1989). The viral 
polymerase  and  cellular  splicing  factors  (serine/arginine-rich  splicing  factor 
SF2/ASF) regulate the splicing of M1 mRNA (Shih & Krug, 1996; Shih et al., 
1995), whereas the splicing of NS1 mRNA was previously speculated to be 
controlled  by  the  NS1  protein  itself  (Garaigorta  &  Ortin,  2007).  However, 
recently it was revealed that the NS1 protein neither auto-regulates the splicing 
of  its  own  viral  NS1  mRNA  nor  affects  the  accumulation  of  NS2  mRNA 
(Robb et al., 2010). 
1.5.5  Cytoplasmic export and synthesis of viral proteins 
Once the viral mRNAs are polyadenylated and capped, these are exported into 
the  cytoplasm  to  be  translated.  The  viral  proteins  are  translated  into  two 
phases: early and late. The viral surface glycoproteins such as HA, NA and M2 
are processed in the endoplasmic reticulum (ER) and glycosylated in the Golgi 
apparatus (Golgi).  All these proteins  carry apical sorting signals that direct 
them to the plasma membrane for virus assembly (Lamb & Krug, 2001). The 
other viral proteins, such as NP and M1, are transported to the nucleus to bind   22 
with vRNA for the composition of vRNPs, while NS1 are partially transported 
to  the  nucleus  to  regulate  antiviral  mRNA  maturation  (discussed  below  in 
detail)  (Hale  et  al.,  2008c).  PB1-F2  localizes  on  mitochondrial  antiviral 
signaling (MAVS) protein to block downstream IFN signaling (Varga et al., 
2011). 
1.5.6  Synthesis of viral RNA 
The  mRNA  transcription  and  subsequent  synthesis  of  viral  proteins  occur 
earlier than the replication of vRNA, due to the need of these proteins in the 
upcoming processes (Nagata et al., 1989; Hay et al., 1977). Later during the 
infection,  the  switch  from  mRNA  transcription  to  replication  of 
complementary  RNA  (cRNA)  and  vRNAs  occurs  in  two  stages:  the  initial 
synthesis of cRNA (+) and copying of cRNA into new vRNA (-) (reviewed in 
Elton et al., 2006; Lamb & Krug, 2001). In spite of the fact that both mRNAs 
and cRNAs are positive sense, mRNAs cannot be used to form new vRNAs 
due to having a 5´host-derived cap, whereas vRNAs cannot be used for protein 
translation due to not having a cap and being encapsidated by the NP protein 
(Elton  et  al.,  2006).  The  three  polymerase  subunits  (PA,  PB1,  PB2)  are 
essential  for  efficient  cRNA  synthesis  (Nakagawa  et  al.,  1996).  The 
polymerase is stabilized by the nuclear importation of newly synthesized NP, 
either by modifying the transcription template (Fodor et al., 1994; Hsu et al., 
1987), or by directly modifying polymerase function (Elton et al., 2006). On 
the other hand, only PA and NP are required for the synthesis of new vRNA 
from cRNA (Elton et al., 2006; Shapiro et al., 1987). 
1.5.7  Packaging of RNA and assembly of virus particles 
The newly synthesized vRNA is transported to the cytoplasm, mediated by the 
M1-NEP complex that remains  attached  to the vRNPs  and this is a tightly 
regulated process (reviewed in Whittaker & Digard, 2006). Additionally, NEP 
interacts with the human CRM1 protein that is responsible for nuclear export 
of vRNPs (Neumann et al., 2000). Once exported to the cytoplasm, all of the 
vRNA segments that carry discrete packaging signals are incorporated into a 
virus particle (reviewed in Bouvier & Palese, 2008). The assembly of viral 
RNAs and viral RNPs occurs only at the apical side of the cell (Boulan & 
Sabatini,  1978).  This  assembly  is  polarized,  which  is  directed  by  the 
independent  targeting  of  viral  HA,  NA,  and  M2  proteins  to  the  apical  cell 
membrane  (Whittaker & Digard, 2006;  Kundu  et  al.,  1996;  Hughey  et  al., 
1992).   23 
1.5.8  Budding and release 
The budding is a complex phenomenon and may involve multiple steps to be 
completed. The initiation of the budding process starts with the deformation of 
the plasma membrane due to clustering of HA and NA (reviewed in Rossman 
& Lamb, 2011). The M1 protein then not only binds to the cytoplasmic tail of 
HA and NA to cause docking, but also recruits the M2 protein at the site of 
budding. It has recently been shown that M2 localizes to the neck of newly 
budding  virions,  which  results  in  membrane  scission  and  virion  release 
(Rossman  et  al.,  2010).  This  process  was  found  to  be  independent  of  the 
endosomal sorting complex transport (ESCRT) machinery, which is a well-
characterized  mechanism  for  budding  of  other  viruses.  The  NA  further 
catalyzes the removal of sialic acid from the infected cells as well as from HA 
and NA molecules. This subsequently results in virus release and prevents self-
aggregation  of  progeny  virions  (Lamb  &  Krug,  2001;  Palese  et  al.,  1974). 
Moreover, it is believed that NA also facilitates the transportation of virions 
through the layers of the respiratory tract (Lamb & Krug, 2001). 
1.6  Reassortment of the influenza A virus gene segments 
Genetic variations within influenza A viruses lead to possible changes in future 
epidemiological behavior and may result in human pandemics. There are at 
least two kind of genetic variations identified:  antigenic drift and antigenic 
shift. Antigenic drift refers to minor changes in the antigenic determinant of 
surface glycoproteins (HA and NA) over the years. These changes are minor 
(0.8% substitutions per year) and have additive effect on the pathogenicity of 
influenza viruses (Robertson et al., 1987). Mechanistically, these modifications 
occur due to the error prone replication of viral RNA polymerase, evolutionary 
pressure, the novel environment of the host, immune pressure, or antiviral drug 
pressure (Landolt & Olsen, 2007; Smith et al., 2004; Domingo et al., 1998). 
Although  these  changes  may  not  lead  to  pandemics,  antigenic  drift  over  a 
period  of  time  can  make  a  strain  considerably  different  from  the  original 
pandemic  virus.  Such  a  scenario  has  been  observed  in  viruses  causing 
pandemics in human history: 1918 to 1956, 1957 to 1967 and 1968 to 1990. 
On the other hand, it is possible that two different subtypes of influenza 
virus,  when  replicating  in  the  same  cell,  may  lead  to  generation  of  novel 
viruses, termed antigenic shift or reassortment. These major changes could lead 
to  emergence  of  new  pandemics,  as  has  been  recently  reported  (swine flu) 
(Figure 6). Due to having both kinds of receptors (α-2,3 and α-2,6 linkage), 
pigs can act as a “mixing vessel”, and this situation is further aggravated due to 
their  susceptibility  to  avian  influenza  viruses.  The  emergence  of  the  Asian   24 
(H2N2)  1957  and  Hong  Kong  (H3N2)  1968  pandemics  was  due  to 
reassortment of three and two viral segments, respectively, whereas the rest of 
the  segments  were  from  the  preceding  strains  (reviewed  in  Kuiken  et  al., 
2006).  To  conclude,  it  is  obvious  that  reassortment  is  the  fundamental 
requirement for influenza A viruses to cause pandemics.  
 
Figure 6. Reassortment of gene segments of influenza A viruses. The genetic characterization of 
recent  swine  flu  virus  (2009A/H1N1)  indicated  that  it  is  a  quadruple  re-assortment  of  four 
different  viruses:  North  American  swine  influenza  (HA,  NS,  NP),  North  American  avian 
influenza (PB2, PA), human influenza (PB1), and Eurasian swine influenza viruses (NA, M). 
1.7  Immune response against influenza A viruses, with special 
reference to IFN induction 
One role of eukaryotic cells is to limit viral replication and spread. For this 
reason, viruses have to cross different layers of the immune system to be able 
to  replicate  (reviewed  in  Randall  &  Goodbourn,  2008).  As  a  part  of  the 
humoral  immunity,  neutralizing  antibodies  can  reduce  the  viral  titer  by  a 
significant  level  by  binding  to  viral  capsid  proteins.  Additionally,  the 
complement system can cause lysis of the virus or promote phagocytosis by 
coating the virions (Lachmann & Davies, 1997). Upon failure of these barriers, 
the  virus  gets  the  chance  to  enter  into  the  cells,  and  this  event  leads  to 
activation  of  different  signaling  pathways.  The  one  prominent  part  of  this 
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cascade is the stimulation of type I interferons (IFN-α/β). The induced IFNs 
then restrict the virus propagation at various levels. 
Different immune cells (such as plasmacytoid dendritic cells) are capable of 
producing type I IFNs to respond quickly to invading pathogens and to prepare 
the neighboring cells (Figure 7). The way that IFN-β expression is induced 
depends upon the mode of entry and the replication of the viruses. The viral 
activation  of  cellular  helicases,  retinoic-acid-inducible  gene  I  (RIG-I)  and 
melanoma differentiation-associated gene 5 (MDA5) and/or toll like receptors 
(TLRs),  mediate  recruitment  of  downstream  signaling  proteins,  which 
terminate at activated IFN regulatory factor 3 (IRF3) and nuclear factor kappa 
B (NF-κB) transcription factors. These are minimal events to initiate the IFN-β 
mRNA transcription. 
 
Figure 7. Induction of IFNs and the antiviral state in eukaryotic cells. The dsRNA, detected by 
either RIG-I/MDA5 or TLRs, initiates downstream signaling from MAVS, TRIF and TRAF3. 
These  adaptors  then  activate  the  IRF3/IRF7,  NF-κB  and  AP-1  transcription  factors  by 
orchestrating the assembly of multi-protein complexes. Once activated, IRF3/7, NF-κB and AP-1 
translocate to the nucleus where they stimulate transcription of IFN-β, among others. Binding of 
IFN-β to IFNAR through auto- and para-crine manners activates the JAK/STAT pathway, and 
terminates at the activated ISGF3 transcription factor. The ISGF3 then translocate to the nucleus 
and  initiate  transcription  of  more  than  300  genes  characterized  in  ISRE  promoters,  which 
subsequently  establish  the  antiviral  state  against  the  invading  pathogens.  See  text  for 
abbreviations. 
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In case of activation of the helicases, double-stranded RNA (dsRNA) of more 
than 30 bp length, produced during viral infection, interacts with RIG-I and 
MDA5 through their N-terminal caspase recruitment domain (CARD) with the 
mitochondrial antiviral signalling protein (MAVS, also known as IPS1, VISA, 
or  CARDIF),  thereby  leading  to  the  activation  of  two  kinase  complexes: 
TANK binding kinase 1-inhibitor of NF-κ kinase ε (TBK1-IKKε) and IKK-α/β 
/γ. TBK1 or IKKε, in turn, phosphorylates IRF3 and IRF7, while the IKK-
α/β/γ complex phosphorylates the IκB protein, which leads to its ubiquitination 
and  proteasomal  degradation,  resulting  in  NF-κB  activation.  The  tripartite 
motif  containing  protein  25  (TRIM25)  has  been  shown  to  ubiquitinate  and 
activate RIG-I (reviewed in Munir, 2010). The optimal induction of IFNs also 
requires  activation  of  c-jun/ATF-2  heterodimer  (reviewed  in  Randall  & 
Goodbourn, 2008). 
In the case of TLRs signaling, dsRNA also interacts with TLR3 (Akira & 
Takeda, 2004), which activates NF-κB and IRF3 transcription factors via the 
TRIF (TIR domain-containing adaptor inducing IFN-β)  adaptor  protein  and 
members of the TNF receptor-associated factor (TRAF) family (Yamamoto et 
al., 2002). 
While being inactive, NF-κB, IRF3/IRF7 and c-jun/ATF-2 (AP-1) remain 
in  the  cytoplasm.  The  activation  signals  lead  to  phosphorylation  of  the  C-
terminus  of  IRF3/7.  The  changes  caused  by  this  modification  lead  to 
dimerization and exposure of the nuclear localization signal (NLS) in IRF3/7. 
This NLS mediates the nuclear translocation of IRF3/7. The inhibitor of NF-κB 
(IκB) keeps the NF-κB in the cytoplasm, which upon receipt of appropriate 
signal undergoes ubiquitination and proteasomal degradation. Removal of IκB 
makes  the  NLS  accessible,  which  leads  to  nuclear  translocation  of  NF-κB 
(reviewed in Hayden & Ghosh, 2004). Phosphorylation of c-jun and ATF-2, 
two heterodimeric components of AP-1, also causes nuclear translocation. 
In the nucleus, these three transcription factors assemble in a cooperative 
manner  to  make  an  enhansosome,  which  binds  to  its  respective  positive 
regulatory domains (PRDs). The IRF3/IRF7, NF-κB and AP-1 bind to PRD 
I/III, PRD II and PRD IV, respectively, where they induce the transcription of 
IFN-α,  IFN-β  and  pro-inflammatory  cytokines  (TNF,  IL6,  IL1β,  etc).  
Following production, IFN-α and IFN-β initiate a positive feedback-production 
loop by binding to the IFN-α/β receptor (IFNAR) in an auto- and para-crine 
manner. Receptor-mediated activation of Janus kinase-signal transducer and 
activator  of  transcription  (JAK-STAT)  signaling  molecules  results  in  the 
recruitment and phosphorylation of IRF9 into the STAT1/STAT2 heterodimer, 
to make interferon-stimulated gene factor 3 (ISGF3) (Mukaigawa & Nayak,   27 
1991). Several protein phosphatases and the suppressors of cytokine signaling 
(SOCS), such as SOCS1 and SOCS3, are found to be involved in negative 
regulation of STATs (Yasukawa et al., 1999). Upon nuclear localization of 
ISGF3, it binds to interferon-stimulated response elements (ISREs) (Kessler et 
al., 1990), which consequently leads to the transcription of hundreds of IFN-
stimulated genes (ISGs). These ISGs play fundamental roles in a wide range of 
cellular  activities,  including  transcriptional  and  translational  regulation  of 
immune responses (de Veer et al., 2001). The collective actions of these ISGs 
make  the  cell  immune  to  invading  pathogens,  and  provide  an  antagonistic 
environment to limit virus propagation and spread. 
1.8  Non-structural protein 1 (NS1) 
In  spite  of  having  multiple  layers  of  eukaryotic  strong  immune  responses 
against influenza A virus, the virus still gets chance to replicate in the host cell. 
In this acquisition, NS1 protein plays an exceptional role. The NS1 protein will 
be discussed comprehensively in the following section. 
1.8.1  Synthesis of NS1 protein 
The eighth and shortest segment (890 nucleotides) of the influenza A virus 
encodes  for  two  mRNAs  in  infected  cells  (Figure  8).  The  translation  of 
collinear  primary  mRNA  results  in  synthesis  of  the  26  kDa  NS1  protein, 
whereas translation of a spliced mRNA give rise to 14 kDa nuclear export 
protein (NEP)  (Inglis  et al., 1979; Lamb & Choppin, 1979).  Both of these 
proteins share 10 amino acids at the N-terminus, which are translated from a 
common 56 nucleotides at 5´ end. After sharing 10 initial residues, a deletion 
of 473 nucleotides occurs by splicing, and translation continues in the +1 ORF 
which  again  results  in  sharing  approximately  ~70  residues  (Lamb  &  Lai, 
1980). Since influenza A viruses encode proteins in both spliced and unspliced 
mRNAs, only 10% of the NS gene segment is spliced (Lamb et al., 1981; 
Lamb  et  al.,  1980).  Until  recently,  it  was  believed  that  the  NS1  protein 
regulates the production of its own viral NS1 mRNA (Smith & Inglis, 1985; 
Lamb  et al., 1978; Skehel, 1972). In contrast, work by Robb et al.  (2010) 
pointed out that the NS1 protein neither auto-regulates the splicing of its own 
viral NS1 mRNA nor affects the accumulation of NEP mRNA (Robb et al., 
2010). 
1.8.2  Structure of the NS1 protein 
The length of NS1 proteins is strain-specific and varies from 202 aa to 237 aa 
(reviewed in Dundon & Capua, 2009). The truncation of ~15 to 30 residues at   28 
the C-terminus has not biologically been shown to be associated with altered 
viral pathogenicity or transmission. However, removal of interacting sites in 
the  C-terminus  (PDZ  ligand,  NLS  and  PABII)  will  confer  an  advantage or 
disadvantage on the virus. Recently, it has been shown that an 11 aa truncation 
in the C-terminus of the NS1 protein did not alter the intracellular localization 
in  both  transfected  and  infected  cells,  indicating  the  nucleolar  localization 
signals  (NoLS)  are  probably  not  crucial  for  nucleolus  localization  of  NS1 
protein. Although the 2009 pandemic virus with an 11 aa truncation in its NS1 
protein was unable to block host gene expression, due to its lack of ability to 
bind with PABII (mapped in these 11 aa truncations), it increased the viral 
pathogenicity in mice (Tu et al., 2011). 
 
Figure 8. Arrangements of NS1 (collinear) and NEP (spliced) mRNAs in the 8
th segment of 
influenza  A  viruses,  and  a  schematic  structural  diagram  of  the  NS1  protein.  The  previously 
characterized residues identified as responsible for particular functions are denoted. 
Structurally, the NS1 protein of influenza A viruses has been divided into two 
distinct functional domains. The dsRNA-binding domain (RBD) comprises of 
the first 73 residues at the N-terminus, and the effector domain (ED) is located 
at  the  C-terminus  (74-230/237).  Both  domains  are  characterized  as  being 
essential for the multi-functionality of the NS1 protein (reviewed in Hale et al., 
2008c; Lin et al., 2007). 
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The RBD exists in a unique symmetric head-to-tail homodimer structure 
with each monomer consisting of three α-helices: residues Asn4-Asp24 (α1), 
Pro31-Leu50 (α2) and Ille54-Lys70 (α3) (α1´, α2´, α3´ are the corresponding 
residues in the antiparallel monomer) (Figure 9 A) (Chien et al., 2004; Chien et 
al., 1997; Liu et al., 1997). The primary role of RBD is to bind to several 
species of RNAs, including dsRNA (Figure 9 A), mRNAs containing poly(A) 
(Qiu & Krug, 1994) and U6 snRNA (Qiu et al., 1995), but it is unable to bind 
with  dsDNA  or  dsRNA-DNA  hybrid  (Lin  et  al.,  2007),  in  a  sequence 
independent manner (Chien et al., 2004; Qian et al., 1995; Hatada & Fukuda, 
1992). It has been proposed that dimerization is essential for the functionality 
of RBD (Yin et al., 2007; Wang et al., 1999). 
Biophysical studies have proposed that the ED of the NS1 protein also form 
a  homodimer,  and  these  dimers  either  exist  in  strand-strand  (Bornholdt  & 
Prasad, 2006) or helix-helix conformation (Xia et al., 2009; Hale et al., 2008a). 
In any case, each monomer consists of three α-helices and seven β-strands. 
Strand-strand  conformation  proposes  that  the  dimer  interface  forms  by  the 
interaction between the first N-terminal β-strand of each monomer, whereas 
helix-helix  conformation  suggests  that  this  interface  is  formed  by  the 
interaction between long α-helices, where Try-187 plays a crucial role in the 
dimerization of EDs (Figure 9 B). The primary function of ED is to mediate 
host-cell protein interactions, and to stabilize the RBD (Hale et al., 2008c). 
 
Figure  9.  Structure  of  the  influenza  A  virus  NS1  protein  (RBD  and  ED).  (A)  Model 
representation of a homodimer of the RBD (PDB file: 1NS1). A hypothetical model is shown 
where dsRNA interacts with RBD, primarily mediated by Arg-38 (red) and Lys-41 (blue). (B) 
Model representation of a homodimer of the ED (PDB file: 3D6R), where a residue (Try-187) 
crucial for ED dimerization is labeled. These images were prepared using MacPyMol. 
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The crystal structure  of the  full-length  NS1 protein  (A/Vietnam/1203/2004) 
recently revealed considerable discrepancies when compared to the individual 
RBD and ED structures (Bornholdt & Prasad, 2008). The authors noted that the 
individual domains (RBD and ED) interact with their respective domains in the 
neighboring NS1 protein, instead of dimerization and formation of a single 
NS1 protein. This leads to the formation of a chain of NS1 molecules with 
altered RBD and ED dimers. It was further proposed that the NS1 chain wraps 
around long dsRNA to form a tubular structure. The dimerization interface for 
ED was different from both models proposed before (strand-strand and helix-
helix). However, it is noteworthy that the structure of this full length NS1 of 
A/Vietnam/1203/2004  exhibits  substitutions  in  nine  amino  acids,  including 
mutations at R38A and K41A, to eliminate its dsRNA binding activity.  
1.8.3  Structural insights into expression pattern of NS1 protein 
The NS1 protein is an essential virulent factor for influenza A viruses, and it 
targets some of its action in the nucleus, including inhibition of the processing 
of host cell pre-mRNA. For efficient action, each domain of the NS1 protein 
carries a specific sequence element that mediates active nuclear import known 
as  NLS  (Greenspan  et  al.,  1988).  The  binding  of  importin-α/β  to  NLS 
containing proteins leads to nuclear translocation via a nuclear pore complex. 
The NLS in RBD (NLS1) is a monopartite (a stretch of four to six arginines or 
lysines)  and  is  mapped  in  highly  conserved  residues  from  35-41,  where 
residues at 35, 38 and 41 are essential for importin-α binding and subsequent 
nuclear translocation; the same residues are also important for interacting with 
dsRNA  (Melen  et  al.,  2007;  Yin  et  al.,  2007)  (Figure  10  A).  Due  to  this 
identical sequence motif in the dsRNA binding and NLS, it was suggested that 
RBD is dynamic in function and may import dsRNA to the nucleus (Melen et 
al., 2007). On the other hand, NLS2 is a bipartite (two stretches of basic amino 
acids are separated by a spacer 10-12 amino acids long) and is located at the C-
terminus of some NS1 proteins. Specifically, Lys-219, Arg-220, Arg-231 and 
Arg-232 constitute NLS2, and with the involvement of Arg-224 and Arg-229 
can also act as NoLS (Melen et al., 2007). The nucleo-cytoplasmic transport is 
mediated by a nuclear export signal (NES) located within the 138-147 residues 
(Li et al., 1998) (Figure 10 B). It has recently been shown that NS1 interact 
with nucleolin (Murayama et al., 2007) and nuclear dot 10 (ND10) structures 
in the nucleus (Sato et al., 2003). The amino acid at position 221 is found to be 
crucial for NLS and NoLS (Han et al., 2010). At this position, allele A of both 
H6N8 and H4N6 strains has lysine (K), while allele B has tyrosine (Y), apart 
from other differences in both NES and NLS (see Figure 15, in results and 
discussion section). Moreover, it has also been suggested that the function of   31 
the NS1 protein is likely to be influenced by the nuclear localization pattern 
(Volmer et al., 2010). 
 
 
Figure 10. The nuclear localization signal 1 (NLS1) in RBD and nuclear export signal (NES) in 
the ED of the NS1 protein. (A) Model representation of the RBD homodimer (PDB file: 1NS1). 
Residues comprising the NLS1 are highlighted in spheres. (B) Model representations of the ED 
homodimer (PDB file: 3D6R). Residues comprising the NES are highlighted in spheres. Images 
were prepared using MacPyMol. 
During infection, the NS1 protein primarily localizes in the nucleus, especially 
at late time points of infection (Newby et al., 2007; Greenspan et al., 1988), 
despite the fact it is considered to be an early protein, as it is expressed at high 
levels in the early course of the infection (Krug & Etkind, 1973). Since the 
NS1 protein contains both NLS and NES, a recent study showed that NS1 
protein was predominantly localized in the cytoplasm during viral infection, 
whereas it was localized in the nucleus under transfection of NS1 constructs 
(Wang et al., 2010). However, the nuclear localization pattern strikingly varies 
between  different  influenza  strains,  and  may  depend  upon  different  factors 
independent of NLSs and NES (reviewed in Hale et al., 2008c). 
1.8.4  Characterization of the NS1 protein: allele A and allele B 
Based on phylogenetic analysis of the nucleotide sequences, the NS gene of 
influenza A viruses can be divided into two gene pools, initially named allele 
A  and  allele  B  (Treanor  et  al.,  1989)  (Figure  11).  Historically,  it  was 
established that the NS segment of human, most swine and equine, and many 
avian  influenza  viruses  belongs  to  allele  A,  whereas  allele  B  exclusively 
contains the strains from avian influenza viruses, with two exceptions (Ludwig 
et  al.,  1991).  Despite  being  a  mammalian  virus,  the  NS  gene  of 
A/equine/Jilin/1/1989/H3N8  was  found  to  belong  to  allele  B  (Guo  et  al., 
1992).  Recently,  another  virus,  originating  from  swine 
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(A/Swine/Saskatchewan/18789/2002/H1N1), was also placed in the allele B 
category  of  influenza  A  viruses  (Zohari  et  al.,  2008a).  The  former  isolate 
caused severe disease and was highly transmissible in equines, whereas the 
later isolate did not appear to be transmitted to other farms. Due to its high 
identity to avian influenza A viruses, it was speculated that isolates in these 
outbreaks originated from an avian source. Nearly all subtypes of avian influenza 
A viruses with a combination of any HA and NA carry both the A and B NS 
alleles.  Furthermore,  there  has  been  no  evidence  of  intermediate  divergence  of 
lineages. This suggests that selection of either of the alleles may be a result of a 
balancing act between influenza A viruses and their hosts (Dugan et al., 2008). 
 
 
 
Figure 11. Phylogentic relationship of allele A and B NS1 genes. The tree was constructed using 
the complete open reading frame for NS1 gene, in MEGA 5.0 with the neighbor-joining method. 
The numbers on key nodes indicate the percentage of bootstrap values of 2000 replicates (only 
values more than 50% are shown). 
The contribution of allele A and B NS1 protein in virulence and pathogenicity 
is  not  entirely  clear.  However,  it  was  speculated  that  the  high  rate  of 
nonsynonymous to synonymous substitution per site (ratio dN/dS) in NS genes 
is a direct indication of NS1 protein adaptive nature in both avian and human 
(Chen & Holmes, 2006). In this regard, it has been shown that a reassortant 
highly pathogenic avian influenza virus subtype H7N1 (A/FPV/Rostock/34), 
when carrying allele B NS gene segment, undergoes attenuation in squirrel 
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monkeys (Treanor et al., 1989). In contrast, recently it was demonstrated that if 
the NS gene segment of A/FPV/Rostock/34 is replaced with the NS segment of 
allele B of A/Goose/Guangdong/1/96 (H5N1) it becomes more virulent and 
can produce infection in mice (Ma et al., 2010). It was further concluded that 
the NS gene segment of H5N1 is crucial to change cell-tropism, host range and 
virus replication. Later, a report from the same group further explained the role 
of allele B in the virus replication (Wang et al., 2010). They demonstrated that 
changing the NS gene segment under the same background alters the antiviral 
response, apoptosis, production of viral RNA and viral transcription. However, 
these alterations were found to be independent of allele-type since the presence 
of allele B NS segment increased the replication in one recombinant isolate 
whereas it did not affect the replication of others, while keeping the rest of the 
seven segments constant (Wang et al., 2010). This discrepancy may likely be 
due to multiple roles of the NS1 protein, at both the viral and host ends. 
In short, it was demonstrated that the presence of the allele B NS gene 
segment facilitates the replication of influenza viruses in accordance with an 
earlier report (Treanor et al., 1989), and to some extent with later reports (Ma 
et al., 2010; Wang et al., 2010). Currently, van Wielink et al. (2011) have 
shown that Madin Darby Canine Kidney (MDCK) cells expressing allele B 
NS1 protein increase the delNS1 influenza virus (influenza viruses without an 
NS1 protein) replication to a significantly higher titer and thus established the 
basis  for  commercial  vaccine  production,  with  the  added  advantage  of 
differentiation  of  infected  and  vaccinated  animals  (DIVA)  strategies  (van 
Wielink et al., 2011). 
It has been observed that the genetic variability between allele A and B can 
be  as  high  as  38%.  However,  both  alleles  are  highly  conserved  among 
themselves, because homology within alleles is found to be 93-100%. Since 
the allele B NS1 protein is under continuous selection pressure, it has been 
proposed that upon entry of allele B influenza viruses into human they might 
undergo high selection pressure and give rise to allele A NS1s (Hale et al., 
2008c). If this is the case, it can be used as an evolutionary marker, and it 
would require in silico analysis to resolve this concern. In accordance to this, it 
has recently been shown that human influenza A viruses are closer to allele A 
than allele B (Chen et al., 2006), and the majority of highly pathogenic avian 
influenza A viruses with the potential to infect humans contain an allele A NS1 
protein (Zohari et al., 2008b). 
An  X-ray  crystallographic  structure  of  the  ED  of  allele  B  NS1  protein 
(A/Duck/Albany/76)  has  recently  been  presented  (Hale  et  al.,  2008a). 
Structural comparison of allele A and allele B (A/Puerto Rico/8/34) (Bornholdt 
& Prasad, 2006) EDs indicated several structural differences. The orientation   34 
of the β-hairpin was found to be different between the two alleles. Although 
the biological function of this region is still to be identified, it is considered 
that the residues in this loop are associated with the cytoplasmic export of the 
NS1  protein.  Although  the  biological  function  remained  unaffected,  the 
orientation of Tyr-89, that is essential for the interaction with phosphoinositide 
3-kinase (P13K) (Hale et al., 2006), was different between allele A and B. The 
orientation of Trp-187, a residue identified as important for interaction with the 
cleavage and polyadenylation specificity factor 30kDa subunit (CPSF30), was 
also not identical. Previously, it had been shown that this site is biologically 
functional in the NS1 protein of A/Duck/Albany/76. On the other hand, the 
NS1  protein  from  A/Puerto  Rico/8/34  did  not  show  any  interaction  with 
CPSF30 (Kochs et al., 2007; Hayman et al., 2006). 
 
 
 
 
Figure 12. A model presentation of the amino acids responsible for interaction with CPSF30 and 
NLS2 in the effector domain. (A) A model structure of the NS1 protein (PDB file: 3F5T). (B) The 
structure of allele A NS1 protein of H6N8 subtype predicted using multiple threading alignments 
on the I-TASSER server (Roy et al., 2010). (C) The model structure of the allele B NS1 protein 
of H6N8 subtype, using the I-TASSER server. The residues involved in mediating interaction 
between NS1 protein and CPSF30 are shown as spheres and labeled in all the structures. The 
residue at position 221 identified as essential for nuclear localization of the NS1 protein is also 
shown in spheres and labeled in both allele A and B NS1 proteins. 
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Recent resolution of the full-length protein structure of the NS1 protein leads 
to the conclusion that the structure of ED alone is considerably different from 
the structure of ED in the full length NS1 protein (Bornholdt & Prasad, 2008) 
(Figure 12 A). A comparison of the ED of A/Puerto Rico/8/34 and of the full-
length protein of A/Vietnam/1203/2004 showed that the ED dimers of full-
length NS1 are more twisted towards the center of each monomer. Although 
the  contribution  of  a  five-residue  deletion  in  the  NS1  linker  region  of 
A/Vietnam/1203/2004 cannot be ruled out, it was suggested that the presence 
of RBD might determine the orientation of these dimers. 
Based on the level of sequence differences between allele A and B NS1 
proteins, it is likely that the 3D structures of allele A and B differ from each 
other, as was indicated previously. Apparently, the in silico structure prediction 
of both alleles NS1 showed considerable differences in the overall orientation 
(Figure 12 B and C). The position of two residues that are characterized as 
functionally important was also found to be either more exposed (allele A, 
Figure 12 B) or more internalized (allele B, Figure 12 C). Based on these 
indications, it would be of particular interest to resolve the complete structure 
of  the  allele  B  NS1  protein,  and  to  compare  the  functional  and  structural 
differences in parallel.  
1.8.5  Mechanisms of NS1 protein in abrogating host IFN responses 
The production of IFNs in response to influenza viruses is certainly a limiting 
factor for viral propagation (illustrated in Figure 7). Therefore, influenza A 
viruses have evolved intrinsic capacities, mainly mediated by the NS1 protein, 
to suppress IFN production, and this act is a prerequisite of influenza A viruses 
replication. The NS1 protein is a relatively small protein that both performs 
and regulates a plethora of cellular activities. The primary role of the NS1 
protein is to counteract the host antiviral responses by participating in both 
protein–RNA and protein-protein interactions. A great wealth of reports has 
demonstrated the molecular mechanisms of the NS1 protein in production and 
downstream effects of IFN. By these reports, it is apparent that most of the 
functions  of  the  NS1  protein  are  either  strain  dependent  or  host  dependent 
(Kochs et al., 2007; Hayman et al., 2006; Geiss et al., 2002). However, the 
well-characterized  functions  of  the  NS1  protein  in  antagonizing  IFN 
production are briefly discussed below. 
Double stranded RNA (dsRNA) sequestration 
The  inhibition  of  IFNs  by  the  NS1  protein  is  primarily  linked  to  dsRNA 
binding  (Lu  et  al.,  1995)  (label  number  1  in  Figure  13).  It  has  been 
demonstrated that dsRNA produced during viral replication must be at least   36 
30-80 bp to elicit type I interferons (IFN-α/β) responses (Wang & Carmichael, 
2004). The NS1 protein has the ability to sequester variable lengths of dsRNAs 
and  to  prevent  exposure  of  dsRNAs  to  any  interactions  for  downstream 
signaling. It has been described that NS1 protein interacts with a wide range of 
RNAs including dsRNA (Wang et al., 1999; Hatada & Fukuda, 1992), viral 
genomic RNA (Hatada et al., 1997), viral mRNA (Marion et al., 1997a; Park 
&  Katze,  1995),  poly(A)-containing  RNAs  (Qiu  &  Krug,  1994),  and  small 
nuclear RNAs (snRNAs) derived from the U6 promoter (Qiu et al., 1995). 
Structural  analysis  has  indicated  that  several  highly  conserved  residues, 
including Thr-5, Pro-31, Aps-34, Arg-35, Arg-38, Lys-41, Gly-45, Arg-46 and 
Thr-49, are involved in NS1-dsRNA interaction either directly or by improving 
stability of this complex (Yin et al., 2007; Wang et al., 1999). Recently, the 
detailed structural arrangement of NS1-dsRNA has unambiguously shown that 
the shallow concave surface of RBD, which is a highly conserved region in the 
NS1 protein, recognizes the major groove of dsRNA (Cheng et al., 2009). An 
influenza  isolate  mutated  at  Arg-38  (R38A)  and  double  mutated  at  Arg-35 
(R35A)  and  Arg-46  (R46A)  completely  abolished  the  ability  of  RBD  to 
interact with dsRNA, indicating that these two positions are critical for this 
interaction.  The  mutations  at  Thr-49  and  Ser-42  residues  reduced  this 
interaction  10-fold,  demonstrating  the  essential  role  of  these  residues  in 
stabilizing  NS1-dsRNA  interaction  (Cheng  et  al.,  2009).  However,  several 
studies  have  shown  that  the  R38A  and  K41A  substitutions  are  enough  to 
disrupt this interaction and to attenuate the virulence (Yin et al., 2007; Wang et 
al., 2002; Wang et al., 1999). 
Interestingly, all of the allele A and B NS1 proteins are conserved at all of 
these  residues.  However,  both  alleles  carry  15  substitutions  in  this  highly 
sensitive region (from position 5-50) for NS1-dsRNA interaction, including a 
stretch of eight consecutive residues (Figure 15, results and discussion section). 
The  biological  significance  of  this  region  in  the  virulence  of  influenza  A 
viruses remains to be addressed. 
NS1 interaction with RIG-I 
Although  it  is  unambiguously  believed  that  the  NS1  protein  sequesters  the 
dsRNA to keep it away from the cellular sensors such as RIG-I, no detectable 
level of dsRNA has been found in influenza A virus infected cells (Weber et 
al., 2006). Further, it has been suggested that other molecular patterns (RNPs, 
single-stranded RNA) may be more dangerous signals for immune responses. 
Consistent with this, it was found that RIG-I directly recognizes the influenza 
A virus ssRNA (Pichlmair et al., 2006). Several studies have demonstrated that 
Arg-38 and Lys-41 are also potentially involved in interaction between the   37 
RIG-I and NS1 protein of PR8 (label number 2 in Figure 13) (Guo et al., 2007; 
Mibayashi et al., 2007; Opitz et al., 2007; Pichlmair et al., 2006). Although 
this  phenomenon  is  not  yet  fully  resolved,  it  is  clear  that 
5´triphophosphorylated ssRNA stabilize the RIG-I-NS1 complex (Pichlmair et 
al., 2006).   
 
Figure 13. Schematic illustration of the multiple functions of the NS1 protein, with primary focus 
on  the  anti-IFN  actions.  The  specific  functions  of  the  NS1  protein  are  labeled  from  1-10, 
according to their sequence of description in the text. See text for detailed description of these 
functions. 
NS1 interaction with TRIM25 
TRIM25  ubiquitinates  and  subsequently  activates  the  RIG-I,  an  essential 
element for downstream signaling. It has recently been described that the NS1 
protein of influenza A viruses not only sequesters dsRNA to prevent it from 
binding to RIG-I but also targets TRIM25, and thus disables the production of 
type I IFNs (Gack et al., 2009) (label number 3 in Figure 13). It has been 
observed that NS1 mediated inhibition of TRIM25-dependent signaling is not 
the  sole  action  of  the  NS1  protein  because  complete  inhibition  of  IFN 
induction in influenza virus-infected TRIM25
-/- mouse embryonic fibroblasts 
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was not observed. Influenza viruses with a double mutation (E96A and E97A) 
abolish the ability of the NS1 protein to inhibit TRIM25, thereby eliminating 
the IFN-suppressive activity of NS1, which leads to efficient IFN production 
and  the  complete  loss  of  virulence  (reviewed  in  Munir,  2010).  These  two 
residues are highly conserved in all NS1 proteins. Both allele A and B NS1 
proteins carry identical residues at position 96 and 97; however substitutions 
were observed in allele B NS1 at both ends of these sites (at 94, 95 and at 98). 
It would be interesting to observe the role of these residues in the stability and 
interaction of the NS1-TRIM25 complex. 
Inhibition of IRF3, NF-κB, AP-1 transcription factors, key regulators of IFN 
production 
The  critical  role  of  three  transcription  factors  (IRF3,  NF-κB,  AP-1)  in  the 
regulation  of  IFN-β  production  is  outlined  in  Figure  7.  The  NS1  proteins 
amazingly target all of these transcription factors to maximize the chances of 
countering the IFN production (label number 4 in Figure 13). Initially, a report 
from Adolfo García-Sastre's lab demonstrated that the NS1 proteins are general 
inhibitors of the interferon-signaling
 pathway, primarily by inhibiting the IRF3 
phosphorylation, and suggested that this inhibition is an important virulence 
factor
 for influenza viruses (Talon et al., 2000). In this report, they noticed that 
in the A/PR/8/34 (PR8)-infected human epithelial cells the NS1 protein could 
not completely prevent the activation of IRF3. This indicates that there could 
be alternative ways for the NS1 to target the innate immune response of the 
host.  Consistent  with  this  hypothesis,  they  further  explained  that  the  NS1 
protein prevents the activation of the virus- or dsRNA-induced NF-κB pathway 
and subsequently antagonizes the IFN-β synthesis (Wang et al., 2000). 
The  molecular  mechanism  behind  the  inhibition  of  these  transcription 
factors is not entirely defined. However, it is likely that the NS1 protein based 
sequestration of dsRNA, a proximal inducer of these transcription factors, may 
lead  to  a  general  prevention  of  IFN  system  activation.  It  was  plausible  to 
hypothesize that the NS1 protein must also inhibit the activation of the AP-1 
transcription factor. Two years later, a report from the same lab identified that 
the NS1
 antagonizes both virus- and dsRNA-induced
 activation of the AP-1 
transcription factor (Ludwig et al., 2002). These findings made it clear that 
inhibition of the IFN system is one of the key functions of the NS1 protein, 
which plays a significant role in the replication and also the pathogenesis of 
influenza A viruses.   39 
NS1 interaction with CPSF30 and PABPII 
Post-transcriptional  modification  of  newly  transcribed  eukaryotic  mRNAs 
(including  IFN-β  mRNAs)  is  an  essential  event  for  their  maturation  and 
function. Cleavage and polyadenylation specificity factor 30kDa (CPSF30) is 
required  for  3´-end  cleavage  and  polyadenylation  of  host  cellular  mRNAs 
(Wahle & Keller, 1996). In addition to CPSF30, a poly(A)-binding protein II 
(PABII) is also required to process the elongation of a short sequence (~10 
nucleotides) at the 3´-end of mRNAs, thereby facilitating rapid processing of 
poly(A) addition (Bienroth et al., 1993). PABII is also an integral component 
of the nuclear export machinery for mRNAs. 
As described above, the sequestration of dsRNA by the NS1 protein is not 
directly related to the level of inhibition of the IFN-β mRNA synthesis. Despite 
this, the production of IFN-β is observed to be decreased in influenza A virus-
infected cells, which leads to the concern of additional viral factors responsible 
to limit the production of IFN-β. In this context, it has earlier been shown that 
the NS1 protein interacts and sequesters the CPSF30 (Nemeroff et al., 1998) 
(label number 5 in Figure 13). As a consequence, IFN-β mRNA produced in 
influenza A virus-infected cells escape the 3´-end processing to form mature 
IFN-β,  and  therefore  the  IFN  response  along  with  other  antiviral  mRNAs 
succumbs (Das et al., 2008; Twu et al., 2006; Noah et al., 2003; Kim et al., 
2002). The crystal structure of the NS1-CPSF30 complex revealed that the ED 
of NS1 requires substantial rearrangements in the original dimer form. In a 
tetrameric  complex,  two  EDs  of  NS1  protein  make  a  head-to-head 
conformation and then interact with second and third zinc fingers (F2F3) of 
CPSF30 (Das et al., 2008). Although, this interaction of the NS1 is mediated 
by amino acid 144 and 184-188 (the 186 region) (Twu et al., 2006; Li et al., 
2001), the F103 and M106 have been described as essential to stabilize this 
tetrameric complex (Das et al., 2008). These sites (F103 and M106) are highly 
conserved,  and  only  three  viruses  including  PR8  show  F103S  substitution. 
Interestingly, PR8, due to having S103, did not bind to CPSF30 both in vitro 
and in vivo (Kochs et al., 2007; Macken et al., 2001). Provided that allele B 
NS1 protein also contains an F103Y substitution, it is valuable to investigate 
the role of 103Y in contrast to 103F and 103S in interaction with the CPFS30. 
On the other hand, a single substitution (G184R) can abolish the ability of the 
NS1 protein to inhibit IFN-β pre-mRNA processing, and is enough to attenuate 
the  virus,  indicating  that  NS1-CPSF30  interaction  is  essential  for  viral 
replication (Das et al., 2008). 
Furthermore, the NS1 protein also interacts with PABPII and blocks the 
elongation of the poly(A) tail of the pre-mRNA, resulting in interference with 
mRNA maturation (Chen et al., 1999). Additionally, this interaction also leads   40 
to  nuclear  retention  of  antiviral  mRNAs,  including  IFN-β  mRNA  (label 
number 5 in Figure 13, nucleus). It has been demonstrated that amino acid 
positions 215-237 or 223-237 are essential for this NS1-PABPII interaction 
(Chen et al., 1999). Being 230 amino acids long, the allele A NS1 protein 
differs from allele B by five or three amino acids respectively, according to the 
prediction. 
Inhibition of mRNA nucleo-cytoplasmic transport by the NS1 protein 
Upon transcription and completion of post-transcriptional modifications, the 
cellular mRNAs need to be exported to the nucleus for translation. The nucleo-
cytoplasmic export is mediated by a set of adapters, such as NXF1, p15, Rae1, 
E1B-AP5, Nup98, hnRNP-like protein and Rae1/mrnp41/Gle2. In addition to 
NS1 interaction with CPSF30 and PABPII, it has recently been found that NS1 
also  interacts  with  essential  components  of  the  mRNA  export  machinery: 
NXF1, p15, Rae1, E1B-AP5 and Nup98 (Satterly et al., 2007) (label number 6 
in Figure 13). In this way, it directly inhibits the mRNA nuclear export with 
simultaneous  retention  of  poly(A)-mRNA,  which  subsequently  impairs  the 
immune responses and enhances the viral virulence. Both domains (RBD and 
ED)  were  found  to  be  involved  in  this  interaction,  but  p15  interacted 
exclusively  with  the  ED  of  the  NS1  protein  (Satterly  et  al.,  2007). 
Additionally, the NS1 protein also makes direct interaction with a novel ~70 
kDa NS1-binding protein (NS1-PB) (Wolff et al., 1998). Co-localization of 
NS1-PB with the SC35, a spliceosome assembly factor, suggests that NS1-BP 
is  involved  in  the  mRNA  splicing  machinery  of  eukaryotes  (Wolff  et  al., 
1998). 
Interestingly,  the  NS1  protein  exclusively  blocks  the  nuclear  export  of 
cellular mRNAs, and it does not inhibit the viral mRNA export. This suggests 
that  viral  mRNA  export  is  independent  of  eukaryotic  nuclear  export 
machinery. However, there are indications that the NS1 protein also block self-
mRNA export (Garaigorta & Ortin, 2007; Satterly et al., 2007). 
Inhibition of IFN signaling by NS1 
The type I IFNs, soon after their secretion, bind to IFNARs and activate the 
JAK/STAT pathway. Until recently, it was not known that the NS1 protein 
interferes in IFN signaling, which left open an option to use type I IFN as a 
therapeutic  agent.  A  recent  study  revealed  that  the  NS1  protein  of  H5N1 
interferes in the type I IFN signaling in three possible ways (Jia et al., 2010). 
First, the NS1 protein down-regulates the IFN α/β receptor subunit IFNAR1 
and  to  some  extent  IFNAR2  expression.  Second,  inhibition  of  STATs 
phosphorylation  leads  to  abolition  of  the  nuclear  translocation  of  STATs   41 
complex  to  initiate  transcription  of  ISGs.  Third,  it  has  further  been 
demonstrated that the expression of NS1 induces up-regulation of the SOCS1 
and SOCS3, which are potent JAK/STAT inhibitors (Jia et al., 2010) (label 
number 7 in Figure 13). Based on these observations, it can be concluded that 
the  NS1  protein  directly  abrogates  the  type  I  IFN  signaling  and  therefore 
facilitates viral replication and virulence. 
Inhibition of IFN-inducible antiviral proteins by NS1 protein 
Apart from multiple ways of IFN production (pre- and post-transcriptional) and 
IFN signaling inhibition, the NS1 protein also specifically blocks the activation 
of  two  cytoplasmic  IFN-inducible  antiviral  proteins:  dsRNA-dependent 
serine/threonine  protein  kinase  R  (PKR)  (Min  et  al.,  2007)  and  2´-5´-
oligoadenylate synthetase (2´-5´-OAS) (Min & Krug, 2006) (Figure 13). 
PKR is maintained as an inactive monomer under normal conditions and 
undergoes activation in response to dsRNA of viral or synthetic origin, such as 
polyinosinic:polycytidylic  acid  [poly(I:C)],  or  by  another  stimulus,  such  as 
PKR-associated activator (PACT). PKR activation by these stimuli is believed 
to disrupt the auto-inhibitory state of PKR, enabling its homo-dimerization and 
auto-phosphorylation,  and  thereby  stimulate  eukaryotic  translation  initiation 
factor 2-α (eIF2-α) substrate binding to block viral protein synthesis (reviewed 
in  Garcia  et  al.,  2006).  Additionally,  PKR  is  also  associated  with  the  up-
regulation of gene expression of different cytokines, including IFN-β, mediated 
through IRF3 and NF-κB responsive promoters (reviewed in Goodbourn et al., 
2000; Sen, 2000). Initially it was believed that the NS1 protein inhibits PKR 
activation by sequestration of dsRNA (Hatada et al., 1999; Lu et al., 1995). 
The efficient inhibition of PKR by dsRNA binding defective NS1 proved that 
it  interacts  in  a  dsRNA-independent  manner,  probably  by  direct  interaction 
with PKR (Li et al., 2006a) (label number 8 in Figure 13). Functional mapping 
studies indicated that residues 123-127 in the ED domain directly interact with 
the N-terminal 230-amino acid region of PKR (Min et al., 2007; Li et al., 
2006a).  Specifically,  substitutions  at  123/124  or  126/127  abolish  the  PKR 
inhibitory  activities  of  NS1  and  render  the  activation  of  PKR  (Min  et  al., 
2007). Subsequently, the viral protein synthesis was dramatically inhibited due 
to phosphorylation and activation of eIF2-α. Provided that PKR is associated 
with  IFN  induction,  inhibition  of  PKR  is  another  role  of  NS1  protein  in 
antagonism of IFN production. 
A putative by-product of influenza virus replication, dsRNA, also activates 
the 2´-5´-OAS, which terminates at the activation of RNaseL pathways. The 
activated RNaseL inhibits viral replication (translation) by degrading single-
stranded RNAs, such as mRNAs and ribosomal RNAs, into short fragments   42 
(reviewed in Sen, 2000). It has been shown that the NS1 protein inhibits the 2´-
5´-OAS pathway, and this function is mapped into the RBD (label number 9 in 
Figure 13). It is further suggested that NS1 has a higher binding affinity for 
dsRNA than 2´-5´-OAS. Given that nuclear fragments, produced as a result of 
2´-5´-OAS/RNaseL  activities,  can  also  activate  the  IFN-β  induction  via 
binding to RIG-I/MDA-5 (Malathi et al., 2007), it is likely that inhibition of 
2´-5´-OAS activity by NS1 may also contribute to limiting IFN-β induction 
(Donelan et al., 2003; Talon et al., 2000). 
Two cellular proteins, P13K and Crk adaptor proteins (Crk/CrkL), play an 
important role in the regulation of multiple host-cell processes, such as anti-
apoptosis, cell growth, proliferation, cytokine production and cell signaling. It 
has been demonstrated that IFN activation of P13K counters many functions of 
STAT signaling. The NS1 protein of influenza A viruses regulates these host 
cell-signaling pathways in a way that would alter to optimize virus replication 
(Hale  et  al.,  2008b;  Heikkinen  et  al.,  2008;  Hale  &  Randall,  2007)  (label 
number 10 in Figure 13).   
Redundant roles of NS1 protein in IFN regulation 
It has been observed that, unlike other influenza A virus infections, PR8 does 
not activate the IRF3, but instead results in the activation of large amount of 
IFN-β cytokine. There are discrepancies behind the molecular mechanism for 
lack  of  IRF3  activation  under  PR8  infection.  The  A/Udorn/72  influenza  A 
virus, when carrying NS1 protein of PR8, activates the IRF3. This suggests 
that the mechanism for absence of IRF3 activation is independent of the PR8-
NS1 protein, and other factors might be involved. Moreover, PR8 is reported to 
interact with RIG-I, which results in IRF3 activation (Mibayashi et al., 2007; 
Pichlmair et al., 2006). The ability of the NS1 protein to limit IFN-α and tumor 
necrosis factor-α induced host-cell gene expression has also been reported in 
several studies (Hale et al., 2008c; Kochs et al., 2007; Hayman et al., 2006; 
Geiss et al., 2002; Seo et al., 2002). These facts lead to the hypothesis that the 
role  of  the  NS1  protein  is  probably  mutually  redundant  in  regulating  IFN 
response and there are anonymous roles of the NS1 protein in this regulation, 
which may depend upon several unidentified factors, from both the viral and 
the  host  ends.  Moreover,  NS1  seems  to  be  an  opportunist  protein,  which 
regulates and modifies its functions depending upon viral need in the course of 
pathogenesis. 
1.8.6  NS1 protein and influenza A virus replication 
The  NS1  protein  plays  a  significant  role  in  enhancing  influenza  virus 
replication,  primarily  by  both  viral  mRNA  synthesis  and  viral  mRNA   43 
translation. It has been noted that a complex of NS1-CPSF30 joins the cellular 
RNA  polymerase  II  to  make  a  macromolecular  complex,  and  contributes 
substantially in the regulation of viral RNA synthesis (Kuo & Krug, 2009; 
Engelhardt et al., 2005). The time of production of influenza A viral proteins is 
either early (NS1 and NP) or late (other proteins, mainly HA and M1), as 
explained  previously  and  outlined  in  Figure  5.  The  NS1  protein  has  been 
shown to temporally regulate the synthesis of viral mRNA and vRNA (Min et 
al., 2007; Falcon et al., 2004; Wolstenholme et al., 1980). A double mutation 
at IIe-123 and Met-124 leads to up-regulation of viral proteins (especially the 
late proteins) early in the infection (Min et al., 2007). Although the molecular 
mechanism is unclear, it is possible that the same substitutions (123 and 124) 
result in the activation of PKR (discussed previously). It is speculated that this 
viral mRNA regulation may be PKR-dependent. Alternatively, interaction of 
NS1 with the viral polymerase complex in infected cells has been suggested to 
play a crucial role in viral RNA synthesis (Min et al., 2007; Falcon et al., 
2004; Marion et al., 1997b). 
Provided that NS1 interacts with the 5´UTR (un-translated region) of viral 
mRNAs (Park & Katze, 1995; Garfinkel & Katze, 1993), it is likely that the 
NS1 protein enhances the translation initiation of viral mRNAs (Marion et al., 
1997a; de la Luna et al., 1995; Enami et al., 1994). In addition to binding with 
viral  mRNA,  the  N-terminal  81  amino  acids  of  the  NS1  protein  have  also 
shown  to  interact  with  poly(A)-binding  protein  I  (PABPI)  (Burgui  et  al., 
2003). Furthermore, the NS1 protein also interacts with eukaryotic translation 
initiation factor GI (eIF4GI) by its N-terminus 113 amino acids (Aragon et al., 
2000). Interaction with these factors leads to enhancement of the translation of 
viral  mRNA,  specifically  by  recruiting  viral  mRNA  translation  initiation 
complexes (label number 11 in Figure 13) (Burgui et al., 2003). 
An hStaufen is a dsRNA and tubulin binding protein, which is implicated in 
the  transportation  of  RNAs  via  its  interaction  with  microtubules,  and 
subsequently enhancement of the translation. The C-terminal effector domain 
of  the  NS1  protein  interacts  with  the  dsRNA-binding  domain  of  hStaufen 
(Falcon et al., 2004). It has been suggested that this interaction may facilitate 
the viral mRNA location in the proper milieu for effective translation. Taken 
together,  interaction  of  NS1  with  cellular  hStaufen,  eIF4GI  and  PABPI 
complex specifically recruits viral mRNA and facilitates efficient translation 
(label number 11 in Figure 13). 
In  summary,  the  influenza  virus  research  community  has  made  several 
breakthroughs in the last few years. As a result of this, it has become clear that 
the NS1 protein evades host immune responses in multiple ways. Here, I have 
discussed quite a few of these functions of the NS1 protein of influenza A   44 
viruses. It has been demonstrated that NS1 proteins play indispensible roles in 
tissue  tropism,  virulence  and  pathogenesis.  Owing  to  their  dynamic  and 
versatile nature, it is essential to identify the most pressing scientific problems 
in  understanding  the  precise  molecular  mechanisms  underlying  the 
multifunctional  character  of  NS1  proteins,  and  to  screen  for  additional 
functions of the NS1 protein. Understanding the biological implication of the 
NS1  protein  would  lead  to  clarification  of  its  roles  in  determining  AIV 
pathogenicity,  virulence,  host  adaptation  and  multifactorial  host-pathogen 
interaction.   45 
2  Aims of the thesis 
The overall objective of this work was to characterize the allele A and B NS1 
proteins  of  avian  influenza  A  viruses  for  their  ability  to  circumvent  host 
immune  responses  and  to  modulate  different  signaling  pathways.  A  further 
focus was to map the structural, functional and species-specific mechanisms in 
which different NS1 proteins may contribute to the pathogenicity of influenza 
A viruses. 
 
The specific aims were to: 
 
ﾧ  Investigate the roles of allele A and B NS1 proteins of influenza A 
viruses, and find whether these proteins have functional preferences 
over inhibition of IFN-β production (Paper I). 
 
ﾧ  Demonstrate the underlying molecular mechanism for the differential 
and allele specific inhibition of IFN-β (Paper II). 
 
ﾧ  Map and compare the structural and functional ability of allele A and 
B NS1 proteins to inhibit dsRNA-induced NF-κB promoter activation 
(Paper III). 
 
ﾧ  Address whether NS1 proteins of allele A and allele B influenza A 
viruses  varied  in  their  capability  to  confer  dsRNA-induced  AP-1 
promoter activation (Paper IV). 
 
ﾧ  Characterize a reassortant  H9N2 isolate and parallel comparison  of 
H9N2-NS1 protein to a highly pathogenic H5N1 for their ability to 
regulate different signaling pathways (Paper V). 
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ﾧ  Investigate  the  molecular  mechanisms  in  the  regulation  of  IFN-β 
production in human and avian cells by the NS1 proteins of H9N2 and 
H5N1 influenza A viruses (Paper V).   47 
3  Materials and methods 
3.1  Influenza A viruses 
The influenza isolates (Table 1) used in the study were grown in the allantoic 
cavity of 9-day-old embryonated eggs and stored at -80 °C until use.  
Table 1. Characteristics of influenza A viruses used in this study. 
a not applicable  
Name of the isolate  Subtype  Allele  Abbreviated 
name 
Accession 
Numbers 
Paper 
A/mink/Sweden/3900/84  H10N4  A  pNS-mink/84  GQ176140  I 
A/chicken/Germany/N/49  H10N7  B  pNS-
chicken/49 
GQ176132  I 
A/mallard/Sw/412/05  H6N8  A  H6N8-A  EU518721  II, III, IV 
A/mallard/Sw/418/05  H6N8  B  H6N8-B  EU518722  II, III, IV 
A/mallard/Sw/818/05  H4N6  A  H4N6-A  EU518757  II, III, IV 
A/mallard/Sw/795/05  H4N6  B  H4N6-B  EU518749  II, III, IV 
A/Puerto Rico/8/34  H1N1  A  PR8-A  CY040174  II 
A/mallard/Sw/754/05  H4N6  A  N/A
a  EU518742  II 
A/mallard/Sw/807/05  H4N6  A  N/A  EU518753  II 
A/mallard/Sw/229/03  H10N8  A  N/A  N/A  II 
A/mallard/Sw/825/05  H4N3  A  N/A  EU518759  II 
A/mallard/Sw/465/05  H3N8  A  N/A  EU518731  II 
A/mallard/Sw/424/05  H6N8  B  N/A  EU518724  II 
A/mallard/Sw/443/05  H6N8  B  N/A  EU518727  II 
A/mallard/Sw/796/05  H4N6  B  N/A  EU518750  II 
A/Chicken/Pak/BYP/2010  H9N2  A  H9N2/NS1  N/A  V 
A/tufted-
duck/Sw/V789/06 
H5N1  A  H5N1/NS1  EU122008  V   48 
3.2  Cell cultures 
A549,  a  type  II  alveolar  epithelial  cell  line  from  human  adenocarcinoma 
(ATCC, CCL-185), Madin Darby Canine Kidney (MDCK) (ATCC CCL-34) 
and Chicken Embryo Fibroblast (CEF) (ATCC CRL-1590) cells were grown in 
Dulbecco's modified Eagle's medium (DMEM), while Mink Lung cells (MiLu) 
were  maintained  in  Eagle's  minimum  essential  medium  with  non-essential 
amino acids. These media were supplemented with 10% fetal bovine serum 
(FBS), 2 mM glutamine, 100 U mL
-1 penicillin, 100 mg mL
-1 streptomycin and 
incubated at 37 °C with 5% CO2 in a humidified (95%) atmosphere. 
3.3  Construction of expression plasmids 
The NS1 expression plasmids used in Papers I, II, III and IV were constructed 
from full-length cDNA of segment 8, using primers: NS1-KpnI-Fw and NS1-
XbaI-Rev (see the individual paper for details). The individual domains (RBD 
and ED) of alleles A and B of NS1 protein of H6N8 were also cloned. All of 
these  products  were  digested  with  KpnI  and  XbaI  at  their  5´  and  3´  ends, 
respectively,  and  cloned  into  a  mammalian  expression  vector  pcDNA3.1+ 
(Invitrogen) at their respective restriction sites (KpnI and XbaI). 
For  the  construction  of  chimeric  NS1  (H6N8  chiNS1  A/B),  the  RNA 
binding domains of H6N8 allele A (A-C-RNA) and ED of H6N8 allele B (B-
C-ED) were amplified using primers as described in paper II. The resulting 
products  were  digested  and  ligated  to  each  other  at  EcoRI  sites.  Similarly, 
H6N8  chiNS1  B/A  was  constructed  by  digestion  and  ligation  of  the  RNA 
binding domain of H6N8 allele B (B-C-RNA) and ED of H6N8 allele A (A-C-
ED). The subsequent products were cleaved at KpnI at the 5´ end and XbaI at 
the  3´  end,  and  were  subsequently  cloned  into  pcDNA3.1+  (Invitrogen) 
(Papers II, III and IV). To create a mutation at nucleotide position 308 in the 
NS1 construct of H6N8 alleles A (T308A) and B (A308T), the M-T308A and 
M-A308T  mutagenesis  primers  were  used,  respectively  (Paper  II).  A 
QuikChange Site-Directed Mutagenesis kit (Stratagene) was applied to create 
specific mutations. 
The constructs used in Paper V were synthesized using NS1-XbaI-Fw and 
NS1-KpnI-Rev. The resultant products were cloned into pCMV-FLAG
®-MAT-
Tag
®-1 (Sigma-Aldrich), another mammalian expression vector carrying a flag 
tag at the N-terminus. 
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3.4  Reporter plasmids 
A set of reporter plasmids was used to screen for different signaling pathways. 
Each reporter plasmid carries a cis-acting enhancer element, responsive to the 
activation of a specific signaling pathway by a suitable stimulus, and tagged 
with a luciferase reporter gene. The reporter plasmids used in these studies are 
summarized in Table 2. 
Table 2. Characteristics of the reporter plasmids used in this thesis. 
Reporter 
plasmid 
Cis-acting enhancer 
element 
Transcription 
factor 
Pathway  Source  Stimulus  Paper 
pISRE-
Luc 
Interferon 
stimulated response 
element 
ISRE  Proliferation/ 
Inflammation 
 
Clontech  dsRNA  I, II, 
V 
pNF-κB-
Luc 
Nuclear factor κB   NF-κB  Proliferation/ 
Inflammation 
/Apoptosis 
Clontech  dsRNA/TNF- 
α 
II 
pAP1- 
Luc 
Activator protein -1  c-jun/c-fos  JNK 
Proliferation/ 
Inflammation 
Clontech  dsRNA  III 
pTA-Luc
a  N/A
b  N/A  N/A  Clontech  N/A  I, II, 
III, 
IV 
4xIRF3-
Luc 
Interferon 
regulatory factor 3 
(PRD I/III) 
IRF3  Proliferation/ 
Inflammation 
Dr. S. 
Ludwig
d 
dsRNA  V 
p125-Luc  IFN-β  ISRE  Proliferation/ 
Inflammation 
Dr. 
Hongxia 
Li
e 
dsRNA  V 
pGL4.74
c  N/A  N/A  N/A  Dr. 
Magnus 
Johansson
f 
N/A  V 
a contains a renilla luciferase gene and was used as an internal control 
b  not applicable  
c contains a renilla luciferase gene and was used as a transfection control to standardize all reporter assays 
d Institute of Molecular Virology, Centre for Molecular Biology of Inflammation (ZMBE), Germany 
e WuHan Institute of Virology, Chinese Academy of Sciences, China
 
f School of Life Sciences, Södertörns University, Sweden 
3.5  Transfections and reporter assays 
All  of  the  luciferase  assays  were  performed  in  24-well  transfection  plates 
(Nunc). The transfection complexes for reporter and expression plasmids were 
prepared with an equal amount of the corresponding plasmids using FuGENE6 
(Roche) (Papers I, II, III and IV). In all of the luciferase assays reported in   50 
Paper  V,  the  transfections  were  performed  using  Lipofectamine  2000 
(Invitrogen)  in  A549  and  CEF  cells,  according  to  the  manufacturer's 
instructions. In all of the studies, freshly passaged A549, MiLu and CEF cells 
were grown in 24-well plates at a density of ~2.5x10
4 cells per well, to attain 
80% confluency by the next day for transfection. After 24 hours of transfection 
(determined from a prior optimization of the assay), the cells were stimulated 
with either poly I:C  (dsRNA)  (Invivogen)  or TNF-α  (Invitro)    in duplicate 
wells for each sample. At the indicated time-points post stimulation, the cells 
were  lysed  with  300  µl  of  lysis  buffer  from  the  Luciferase  Assay  Kit 
(Stratagene) (Paper I), or 100 µl of One Glo Luciferase Substrate (Promega) 
(Paper  II,  III  and  IV)  or  100  µl  of  1x  passive  lysis  buffer  in  the  Dual-
Luciferase  Reporter  Assay  System  (Promega)  (Paper  V).  The  luciferase 
activity was measured in luminometer plates (Nunc), and analysed by reading 
luminescence in a Wallac Victor
2™ 1420 Multilabel counter (Wallac Sverige 
AB). Each transfection experiment was repeated at least three times, and the 
average  value  of  the  luminescence  readings  was  calculated  and  normalized 
with renilla luciferase activity. 
In Paper II, A549 cells were transfected with the ISRE reporter plasmid for 
24  hours,  followed  by  infection  with  influenza  viruses  at  a  multiplicity  of 
infection  (MOI)  of  5.  Firefly  luciferase  activity  was  determined  in  the  cell 
lysates using One Glo Luciferase Substrate, as described above. 
3.6  In situ proximity ligation assay (in situ PLA) 
A549 cells were seeded in 8-well chambers (VWR international) for 24 hours, 
followed by transfection with the indicated amount of NS1 constructs using 
Lipofectamine 2000 (Invitrogen). After the indicated time post transfection, 
cells were fixed and permeabilized. The cells were incubated  with primary 
antibodies raised against the C-terminus of the NS1 protein (ProSci) (Papers II, 
III and IV) or anti-flag (Sigma-Aldrich) (Paper V). Afterwards, the cells were 
incubated with anti-rabbit PLUS and anti-rabbit MINUS (Papers II, III and IV) 
or anti-mouse PLUS and anti-mouse MINUS (Paper V) proximity-probes at 
37° C for 2 hours. Thereafter, the probes were hybridized and the ends ligated, 
followed  by  amplification  of  the  ligated  probes  using  rolling  cycle 
amplification.  Finally,  the  cells  were  incubated  in  a  detection  solution 
containing  a  fluorescently  labeled  detection  oligonucleotide.  Slides  were 
visualized  under  standard  immunofluorescence  microscope  (Nikon)  using 
suitable filters for Texas red (PLA) and DAPI (nuclear) staining. 
To quantify the in situ expression levels of the NS1 proteins, BlobFinder 
software V3.0 (Uppsala University, Uppsala, Sweden) was used.   51 
3.7  Western blotting 
For the detection of NS1 protein expression, transfections of the indicated NS1 
constructs were performed in 24-well plates using FuGENE6 (Roche) (Paper I) 
or Lipofectamine 2000 (Invitrogen) (Papers II, III, IV and V). At the indicated 
times,  cells  were  washed  and  lysed  using  Bio-Plex  cells  lysis  kit  (Bio-Rad 
Laboratories)  (Papers  I,  II,  III  and  IV)  or  NP40  lysis  buffer  (Paper  V). 
Concentration  and  quality  of  the  lysate  were  measured  using  Nanodrop 
ND1000 (Nanodrop Tec.). A total of 50 µg of lysate was separated by sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in Ready Gel 
J  7.5%  (Bio-Rad  Laboratories)  and  then  transferred  to  a  polyvinylidene 
difluoride (PVDF) membrane (GE Healthcare). The membranes were blocked 
(PBS, 2% (wt/vol) bovine serum albumin) at room temperature for 1 hour. 
Thereafter, the membranes were incubated with NS1 antibodies raised in goat 
against a peptide mapping near the C-terminus of influenza A NS1 (Santa Cruz 
Biotechnology)  (Paper  I)  or  NS1  antibodies  raised  in  rabbit  against  the  C 
terminus of NS1 protein (ProSci) (Papers II, III and IV), or antibodies raised in 
mouse against flag tag (Paper V) and β-actin from Sigma-Aldrich (Paper I) or 
from ProSci (Paper V), at 4 °C overnight. After washing with PBST (PBS, 
0.2%  Tween  20),  membranes  were  incubated  with  horseradish  peroxidase 
(HRP)-conjugated anti-rabbit or anti-mouse or anti-goat secondary antibodies 
for  2  hours  at  room  temperature  with  continuous  agitation.  The  blots  were 
developed  by  an  ECL  advance  kit  from  GE  Healthcare,  and  visualized  by 
ChemDoc XRS system from Bio-Rad with Quantity One
® software. 
3.8  Quantification of IFN-β by ELISA 
To measure the secreted IFN-β in cell supernatants, a commercially available 
VeriKine  sandwich  ELISA  kit  (PBL  Biomedical  Laboratories)  was  applied 
according to the manufacturer's instructions. A standard curve was established, 
and the titer of IFN was calculated using MasterPlex ReaderFit software. 
3.9  Quantitative real-time PCR (qPCR) for pre- and mature-IFN-
β mRNA 
To measure the level of pre- and mature-IFN-β mRNA inhibition by the NS1 
proteins of different influenza A subtypes, A549 cells were seeded into six-
well  plates.  Cells  were  transfected  with  the  indicated  NS1  constructs  and 
stimulated  with  dsRNA.  The  cells  were  lysed  using  TRIzol  Reagent 
(Invitrogen) at 0, 2, 4, 8, 16 and 24 hours post stimulation. RNA was extracted 
using the RNeasy Mini kit, and treated with DNase using on column DNase   52 
Digestion Kit (Qiagen) to remove any DNA contamination. To measure the 
IFN-β pre-mRNA, the total RNA was reverse transcribed into cDNAs using 
20-mer oligonucleotides which target the sequence upstream the poly(A) tail 
(Paper V). For mature-IFN-β mRNA quantification, the total RNA was reverse 
transcribed using Oligo(dT)20 (Invitrogen), which targets the poly(A) tail of 
mature  IFN-β  mRNA  (Paper  V).  Both,  pre-  and  mature-mRNAs  were 
quantified using Brilliant II SYBR Green QRTPCR Master Mix Kit (Agilent 
Technologies) with oligonucleotides for IFN-β (Papers II and V), as per the 
manufacturer's instructions. To normalize the loading cDNA, β-actin was run 
in parallel at all time points using forward (5´-TGG GTC AGA AGG ACT 
CCT ATG-3´)  and  reverse  (5´-AGA AGA GCT ATG AGC TGC CTG-3´) 
primers. The results were presented as fold increase in IFN-β mRNA using the 
2
-
ΔΔT method. 
3.10  VSV-GFP IFN bioassay 
For quantitative measure of IFN-β inhibition by the NS1 proteins of H9N2 and 
H5N1, A549 cells were seeded in 8-well chamber slides (VWR international). 
Transfections  were  performed  using  Lipofectamine  2000  (Invitrogen). 
Eighteen hours post transfection incubation period, cells were stimulated and 
infected  with  vesicular  stomatitis  virus  (VSV)  expressing  GFP  (VSV-GFP) 
with an MOI of 2. The fluorescence intensities were measured at 18 hours post 
infection.  Images  were  taken  using  an  immunofluorescence  microscope 
(Nikon) (Paper V). 
3.11 IRF-3 nuclear translocation assay 
The NS1 constructs for H9N2 and H5N1 were transfected in A549 and MDCK 
cells in 8-well chamber slides (VWR international) using Lipofectamine 2000 
(Invitrogen). At 24 hours post-transfection incubation period, phosphorylation 
of IRF3 was stimulated with 10 µg of dsRNA. At 24 hours post stimulation, 
cells were fixed in 1% paraformaldehyde for 40 minutes. Then the cells were 
incubated with anti-pIRF3 (Ser396) rabbit monoclonal antibodies (Millipore), 
followed  by  incubation  with  Cy3-mouse  anti-rabbit  IgG  as  secondary 
antibodies (Jackson Immuno Research). The nuclear localization of activated 
IRF-3 was examined with a standard immunofluorescence microscope (Nikon) 
using suitable filters for Texas red (IRF3) and DAPI (nuclear) staining (Paper 
V).   53 
3.12 Genetic characterization and phylogenetic analysis 
The H9N2 influenza virus was isolated from backyard poultry flocks, and was 
biologically  characterized  using  standard  hemagglutination-inhibition  (HI), 
neuraminidase inhibition assay and intravenous pathogenicity index (IVPI) at 
the  Poultry  Research  Institute  (PRI),  Lahore,  Pakistan.  For  genetic 
characterization,  the  eluted  RNA  from  impregnated  Qiacard  FTA  Indicator 
(Qiagen)  was  used to sequence all of the  gene  segments  at  SLU,  Uppsala, 
Sweden.  The  phylogenetic  analysis  was  performed  on  the  basis  of 
hemagglutinin,  neuraminidase  and  non-structural  genes  in  the  Molecular 
Evolutionary Genetics Analysis (MEGA, version 5) software package (CEMI, 
Tempe, AZ, USA) using the neighbor-joining (NJ) method. To confirm the 
genetic pattern demonstrated by the NJ method, the trees were also constructed 
using Bayesian Inference with the program MrBayes version 3.1.2 (Paper V). 
3.13 Statistical analysis 
Data were analyzed for statistical significance applying Student t-test. P values 
of ≤0.05 were deemed to be statistically significant. 
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4  Results and discussion 
4.1  Strategies of allele A and B NS1 proteins to counteract IFN-
β production and their contributions in viral pathogenicity 
(Papers I and II) 
 
In the early 1980s, a H10N4 subtype of influenza A viruses  (IAV)  caused 
severe infection in mink on the South-East coast of Sweden. Considering that 
the outbreak was caused by an avian virus (Englund et al., 1986; Klingeborn et 
al., 1985), an in vivo study was conducted in which mink were intranasally 
infected  with  mink  (mink/84)  and  avian  (mallard/85,  fowl/85,  chicken/49) 
isolates (Berg et al., 1990). Interestingly, all isolates caused disease and were 
transmitted by contact except chicken/49. Moreover, there was a difference in 
the abilities of mink/84 and chicken/49 to induce interferon (IFN) response 
(Englund, 2000; Englund & Hard af Segerstad, 1998). 
In a recent study conducted to establish the reason behind this apparent 
difference  in  pathogenicity  and  virulence,  it  was  revealed  that  the  isolates 
(mink/84, chicken/49) have different NS gene segments, where mink/84 was 
found  to  carry  allele  A  and  chicken/49  carries  allele  B  NS  gene  segments 
(Zohari et al., 2010). Until then, this division of influenza A viruses (allele A 
and B) had been based purely on the putative amino acid sequence of the NS 
gene (Treanor et al., 1989). However, it had been established that allele B 
exclusively contained strains of avian origin, while allele A comprised strains 
of both avian and mammalian (human, equine and swine) origin (Ludwig et 
al.,  1991),  with  one  exception.  Despite  being  a  mammalian  virus, 
A/equine/Jilin/1/1989/H3N8  was  found  to  belong  to  allele  B  (Guo  et  al., 
1992).  Recently,  another  virus  originating  from  swine 
(A/Swine/Saskatchewan/18789/2002/H1N1)  was  also  placed  in  the  allele  B 
category of influenza A viruses (Zohari et al., 2008a). However, it should be   56 
noted that all of the eight segments of these two influenza A isolates show high 
identity to that of avian influenza A viruses, an indication of their origin from 
an avian source. 
It  was  plausible  to  hypothesize  that  the  difference  in  the  pathogenicity 
between mink/84 and chicken/49 might be NS1 allele dependent, primarily, 
due to the fact that allele A NS1 protein differs from allele B NS1 protein by 
over 30% of their amino acids (Figure 15). In line with this, it was reported 
that highly pathogenic avian influenza viruses, with the potential for human 
direct transmission, mainly contain the allele A NS1 protein (Zohari et al., 
2008b). Applying a model system in which A549 cells were co-transfected 
with  NS1  protein  expression  plasmids,  and  a  pISRE-Luc  reporter  plasmid 
under the stimulation of poly I:C (dsRNA), it was possible to demonstrate that 
mink/84 NS1 causes 85.3% inhibition of ISRE promoter activity. In contrast, 
chicken/49 NS1 caused a considerably weaker inhibition of ISRE promoter 
activity with only 20.8%. A similar pattern was observed in a homologous cell 
culture system, mink lung cells (MiLu). To exclude the possibility that the 
difference was due to IFN-β mRNA transcription or IFN-β signaling, RT-PCR 
and  ELISA  were  applied,  respectively,  which  confirmed  the  results 
demonstrated in the luciferase assays (Paper I). 
Thus,  it  was  confirmed  that  mink/84  and  chicken/49  inhibit  IFN-β 
production  in  a  manner  dependent  on  allele  type,  and  the  concept  of  the 
essential  role  of  allele  A  and  B  NS1s  in  the  pathogenicity  of  influenza  A 
viruses was established. Nonetheless, it was obvious that the NS1 protein can 
act as an essential determinant of influenza virus pathogenesis and virulence. 
However, there were several concerns to be addressed in more detail: (i) since 
the mink/84 (H10N4) and chicken/49 (H10N7) carry different neuraminidase 
(NA) genes, the apparent difference in pathogenicity might be species-specific; 
(ii)  the  contribution  of  alleles  (A  and  B)  in  the  inhibition  of  type  I  IFN 
promoter activities might be influenza A virus subtype-specific; (iii) the NS1 
protein is a multifunctional protein, which interferes in type I IFN production 
at multiple steps in ways more than one, and the molecular mechanism behind 
this allele-dependent type I IFN inhibition would be of special interest; (iv) this 
inhibition of type I IFN promoter activity might be cell-type specific; (v) the 
structural motifs in the NS1 proteins (allele A and allele B) responsible for this 
difference  are  still  unknown;  (vi)  apart  from  IFN  inhibition,  what  is  the 
implication of allele A and B NS1 protein in the pathogenicity of influenza A 
viruses;  and  finally  (vii)  what  is  the  biological  importance  of  such 
discrepancies in allele A and allele B dependent viral replication?   57 
 
 
Figure 14.  Screening of several subtypes of influenza A  viruses  for the ability  of their NS1 
protein to block dsRNA-induced pISRE activity. Human A549 cells were co-transfected for 24 
hours  with  NS1  expression  plasmids  and  pISRE-Luc  reporter  plasmids.  ISRE  promoter  was 
stimulated with poly I:C for the next 24 hours. Luciferase activity was measured 24 hours post 
stimulation.  The  data  represents  the  average  of  three  independent  experiments  performed  in 
duplicate. Allele A NS1s can clearly be differentiated from allele B NS1 proteins based on their 
level  of  ISRE  promoter  inhibition.  *  indicates  significant  differences  between  the  compared 
isolates. 
 
In order to address some of these concerns, an extensive study was designed 
especially  to  understand  the  molecular  mechanism  behind  the  difference  in 
IFN-β inhibition (Paper II). In an initial screening, NS1 proteins from various 
avian  influenza  A  subtypes  (H6N8,  H4N6,  H10N8,  H4N3,  H3N8,  H1N1) 
representing  both  allele  A  and  allele  B,  were  evaluated  for  their  ability  to 
inhibit  dsRNA-dependent  ISRE  promoter  activation.  Based  on  the  level  of   58 
inhibition, allele A influenza A viruses can clearly be differentiated from allele 
B, where the level of ISRE promoter inhibition was stronger (up to 87%) in 
allele A than in allele B (up to 45%) (Figure 14). For deeper analysis, two 
subtypes (H6N8 and H4N6), each comprised of isolates having both alleles A 
and B NS1 proteins were chosen. These viruses were identical regarding other 
viral proteins (with few amino acid differences at uncharacterized positions) 
except for the NS gene segment. 
 
Figure 15. Alignment of the amino acid sequences for alleles A and B of H6N8 and H4N6 along 
with PR/8 used in this study (Papers I, II, III and IV). The dots represent identical residues to that 
of PR/8. NLS1 (aa 34–38), NES+regulatory sequence (aa 134–161), NLS2 (aa 216–230) and site 
of mutagenesis (aa 103) are underlined. The arrow indicates the NS1 chimeras's and individual 
domain's break points. The amino acids having similar properties were assigned the same color. 
As  outlined  in  Figure  7  (introduction  section),  the  ISRE  promoter  is 
downstream of IFN transcription, IFN production and subsequent signaling. It 
was of interest to investigate the abilities of allele A and B NS1 proteins to 
interfer  with  IFN  production  at  the  specific  level.  It  has  recently  been 
demonstrated that the expression of NS1 induces up-regulation of the SOCS1 
and SOCS3, which are potent JAK/STAT inhibitors (Jia et al., 2010). Since 
alleles A and B differ in the suppression of the ISRE promoter, it is plausible 
to hypothesize that this difference is due to the interactions and inhibition of 
the JAK/STAT pathway, downstream to IFN receptors, which might reflect the 
additional effects of the immune evasion potential of different NS1s. However, 
quantification of the IFN-β protein in NS1 transfected and dsRNA stimulated 
cells demonstrated that the difference between alleles A and B was due to a 
difference in the mechanism(s) involved in IFN-β production in the presence of 
NS1, and not due to signaling from the IFN receptors (Figure 16 A), which was 
further confirmed by the results of luciferase assay at the corresponding time 
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points (Figure 16 B). Further, upstream to IFN-β production is the transcription 
of  IFN-β  mRNA,  primarily  initiated  by  the  cumulative  action  of  three 
transcription  factors  (IRF3,  NF-κB  and  AP-1)  (Maniatis  et  al.,  1998).  The 
results of qRT-PCR showed that the difference in IFN-β protein expression 
was due to alteration in the IFN-β mRNA transcription, thus indicating that the 
underlying difference resides in differential NS1 suppression of IFN induction 
(pre-transcription IFN suppression). However, the biological implications and 
the  mechanisms  underlying  the  differences  between  allele  A  and  B  NS1 
proteins in counteracting the IFN-α/β response warrant further investigation. 
 
Figure 16. Inhibition of dsRNA-induced IFN-β protein expression and ISRE promoter inhibition 
by allele A and B NS1 proteins of H6N8 and H4N6. (A) A549 cells were either mock-treated or 
transfected with corresponding NS1 expression plasmids. Cell supernatants were collected at 0, 2, 
4, 8, 16 and 24 h post dsRNA stimulation, and were subjected to an ELISA. (B) A549 cells were 
either  mock-treated  or  transfected  with  ISRE  signaling  plasmid  or  co-transfected  with  ISRE 
signaling plasmid and NS1 expression plasmids for 24 h, and luciferase activity was measured at 
0, 2, 4, 8, 16 and 24 h post dsRNA stimulation. 
Despite the fact that most of previously characterized residues are identical in 
both alleles, genetic characterization of allele A and B NS1 proteins of H6N8 
and H4N6 showed the presence of two substitutions at two critical regions 
(Zohari et al., 2008b). One substitution was observed in the NS1 protein in 
which it interacts with the CPSF30. This interaction with the CPSF30 inhibits 
3´-end processing of cellular pre-mRNA and thus leads to its nuclear retention 
(Li  et  al.,  2001;  Chen  et  al.,  1999;  Nemeroff  et  al.,  1998).  Two  distinct 
domains mediate this function: one around residue 186 (Li et al., 2001) and the 
other around residues 103 and 106 (Kochs et al., 2007). It was further shown 
that mutations at the NS1-CPSF30 interaction sites dramatically changed the 
effect of the NS1 controlling host gene expression. The NS1 protein of allele A 
possessed  the  amino  acids  Glu186,  Phe103  and  Met106,  whereas  the  NS1 
protein of allele B possessed Glu186, Tyr103 and Met106. Therefore, to test 
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the contribution of the amino acid at position 103 in post-transcriptional pre-
mRNA processing, this position was exchanged both in allele A (Phe103 to 
Tyr103) and in allele B (Tyr103 to Phe103). The luciferase activity evaluated 
for the ISRE promoter in A549 and MiLu cells transfected with mutant clones 
did not differ significantly from the wildtype, consistent with a previous report 
(Twu et al., 2006), though weak variation was observed in A549 cells (Paper 
II). 
Another  substitution  was  observed  at  position  221,  a  site  that  has  been 
demonstrated  to  be  crucial  for  NLS  and  NoLS  (Han  et  al.,  2010).  At  this 
position, allele A of both H6N8 and H4N6 strains has a lysine (K) residue, 
while allele B has tyrosine (Y), apart from other differences in both NES and 
NLS (Figure 15). Moreover, it has also been suggested that the function of the 
NS1 protein is very much influenced by the nuclear localization pattern of the 
NS1 protein (Volmer  et  al.,  2010).  The  observed  difference  at  earlier  time 
points post-transfection might interfere with the processing and export of newly 
synthesized mRNA. A similar pattern has been observed for A/Udorn/72 and A/ 
Victoria/3/75, to which allele A shows high sequence similarity (Hayman et al., 
2006;  Qian  et  al.,  1994).  It  was  further  demonstrated  that  accumulation  of 
A/Victoria/3/75 NS1 in the nucleus of COS-1 cells results in the nuclear retention 
of mRNA (Fortes et al., 1994; Portela et al., 1985). The localization pattern was 
found to be different (cytoplasmic) during infection of influenza A viruses than 
transfection of NS1 constructs (nuclear) (Wang et al., 2010), which warrants 
further  investigation  to  ascertain  the  biological  relevance  of  this  nuclear 
location pattern in viral replication and pathogenicity. 
In order to map the structural basis of the IFN-β inhibition, each domain of 
the  NS1  proteins  of  both  allele  A  and  B  H6N8  subtype  was  constructed. 
Results based on the dsRNA-induced ISRE promoter activities in both A549 
and MiLu cells indicated that the ability to block ISRE promoter is exclusively 
mapped into the ED, whereas the RBD alone is unable to block ISRE promoter 
activity. This is in accordance with earlier reports where it was demonstrated 
that dimerization of NS1 protein is a pre-requisite for the functionality of RNA 
binding domain (Wang et al., 1999). It was further shown that the ability of 
multimerization/dimerization was mapped to the effector domain of the NS1 
protein from amino acid 134-161 (Wang et al., 2002; Nemeroff et al., 1998), 
and that the amino acid at position 149 plays a crucial role for this dimerization 
and subsequent pathogenicity by antagonizing interferon induction (Li et al., 
2006b). Therefore, it is obvious that the RNA binding domain alone remained 
non-functional, and hence did not affect the dsRNA induced ISRE promoter 
activities.   61 
These results were further confirmed by the analysis of the chimeric NS1 
proteins carrying either RBD of allele A and ED of allele B (H6N8 chiNS1 
A/B) or vice versa (H6N8 chiNS1 B/A). In either of these chimeric variants, 
the NS1 protein re-gained the ability to inhibit type I IFN induced promoter 
activity.  These  results  further  validate  the  idea  that  the  two  domains  are 
probably functionally interactive in a co-operative manner resulting in their 
overall IFN antagonism properties. It is also likely that the difference between 
the  two  NS1  proteins  influences  the  three-dimensional  structure  and 
dimerization  of  the  NS1  protein,  which  affects  the  function  of  NS1  in  the 
suppression of IFN-β promoter activation. It is noteworthy that both allele A 
and  B  NS1  proteins  possess  an  eight  continuous  amino  acids  motif 
(
21RFADQELG
28  and 
21LLSMRDMC
28).  This  motif  most  likely  reflects 
differences in the respective protein function, and would be interesting to study 
in terms of the biological significance in the context of viral infections. 
While  these  experiments  were  in  progress,  an  increase  was  observed  in 
research on the contribution of the allele A and B NS gene segment in viral 
pathogenicity, virulence and replication. A study by Ma et al. (2010) showed 
that  A/FPV/Rostock/34  (H7N1),  when  carrying  allele  B  of  A/Goose/ 
Guangdong/96 (H5N1), had increased infectivity in mice and replicated more 
efficiently in human and mouse cell lines than wild-type H7N1. In contrast, an 
earlier  study  demonstrated  that  an  avian  virus  (A/FPV/Rostock/34,  H7N1), 
containing an allele A NS1, replicates efficiently in mammalian cells, while 
reassortants, containing an allele B NS gene, were shown to replicate poorly in 
the  upper  and  lower  respiratory  tract  of  squirrel  monkeys  (Treanor  et  al., 
1989). Consistent with the previous reports that the presence of allele B NS 
gene segment facilitates the replication of influenza A viruses, recently van 
Wielink et al. (2011) showed that MDCK cells expressing the allele B NS1 
protein increased the delNS1 influenza virus replication to significantly higher 
titers, and thus established the basis for commercial vaccine production with 
the added advantage of DIVA strategies (van Wielink et al., 2011). Studies 
have also highlighted that the NS gene segment of avian influenza A viruses 
plays essential roles in host-adaptation, cell-tropism and virulence of influenza 
A viruses (Ma et al., 2010; Wang et al., 2010).  
All these facts lead to a general concept that the NS1 protein of allele A is 
genotypically  and  phenotypically  different  from  allele  B  NS1  proteins  of 
influenza A viruses. This raised interest to investigate previously characterized 
functions of NS1 protein in the context of allele A and B contributions.   62 
4.2  Regulation of NF-κB and AP-1 transcription factors by the 
allele A and B NS1 proteins of influenza A viruses (Papers 
III and IV) 
In the first part of the study, we established a concept that allele A and B NS1 
proteins  differentially  regulate  IFN-β  production,  as  demonstrated  by  ISRE 
promoter activation, IFN-β mRNA transcription and IFN-β protein expression, 
despite  the  efficient  expression  of  both  allele  A  and  B  NS1  proteins.  The 
maximal production of IFN-β is regulated by different transcription factors, 
namely interferon regulatory factor 3/7 (IRF3/7), nuclear factor κB (NF-κB) 
and activating protein 1 (AP-1) (Maniatis et al., 1998). The binding of IRF3/7 
to positive regulatory domains I and III (PRD I and III), NF-κB on PRD II and 
AP-1 on PRD IV initiates the transcription of IFN-β mRNA. The endogenous 
dsRNA,  a  by-product  of  viral  replication,  or  synthetic  dsRNA  (poly  I:C) 
activates  all  of  these  transcription  factors  through  a  complicated  set  of 
pathways (Iwamura et al., 2001). 
It is likely that the allele A NS1 proteins of influenza A viruses interfere in 
these transcription pathways more strongly than allele B NS1 proteins, and 
hence result in stronger inhibition of IFN-β mRNA transcription. To address 
this question, reporter plasmids that carry the luciferase gene under the control 
of a synthetic NF-κB binding site (pNF-κB-Luc) or AP-1 binding site (pAP-1-
Luc) were used. The effect of allele A and B NS1 proteins of H6N8 and H4N6 
(the same isolates used in the previous study, in order to maintain consistency) 
expression  was  evaluated  on  dsRNA-induced  NF-κB  and  AP-1  promoter 
activation. 
The results showed that there was a high activation of NF-κB promoter 
activation in mock-NS1 transfected A549 cells. However, with the addition of 
NS1  from  either  of  the  subtypes  or  alleles  clearly  diminished  the  NF-κB 
promoter activation. Although the level of inhibition of NF-κB promoter was 
evident for both alleles (A and B), surprisingly it was significantly higher in 
allele A (~80%) compared to allele B (H6N8-B=30% and H4N6-B=40%) (p 
<0.05) (Figure 17). In order to exclude the possibility that this role of allele A 
and  B  NS1  proteins  might  be  species-specific,  this  pathway  was  further 
examined in mink lung cells (MiLu). A similar pattern was seen, where allele 
A NS1 proteins of both influenza A subtypes were consistently better (84% 
and 80% in H6N8 and H4N6) in blocking the induction of NF-κB promoter, 
compared to allele B NS1 proteins (46% in H6N8 and 37% in H4N6) (Figure 
17). 
The activated NF-κB pathway has been identified as essential for efficient 
viral replication (Nimmerjahn et al., 2004) by increasing the vRNA synthesis 
(Kumar et al., 2008). On the other hand, the NS1 protein of avian influenza A   63 
viruses has been shown to inhibit activation of NF-κB (Wang et al., 2000). 
This act is probably essential for balancing the optimal induction of NF-κB to 
prevent the hyper-activation of this transcription factor. Keeping in mind that 
the  presence  of  the  allele  B  NS1  protein  facilitates  viral  replication  (van 
Wielink et al., 2011; Ma et al., 2010), it is tempting to postulate that in the 
context of an influenza A virus infection weaker inhibition of NF-κB by allele 
B NS1 protein appears to have a supportive function for viral replication that is 
dominant over its antiviral activity. 
 
Figure 17. Differential inhibition of the NF-κB and AP-1 promoters by allele A and B NS1 
proteins of avian influenza A viruses in A549 and MiLu. Both cell lines were co-transfected with 
each of the NS1 expression plasmids (H6N8-A, H6N8-B, H4N6-A or H4N6-B), along with either 
pNF-κB-Luc or pAP-1-Luc reporter plasmid or empty plasmid. After an incubation period of 24 
hours, the cells were stimulated with dsRNA (10 µg/ml). After another 24 hours, cells were lysed 
and luciferase activity was determined. The mock treated control (Signaling Cont.) was set to 
100%, and the level of inhibition was reported in percentage. The data presented here correspond 
to three experiments with transfections performed in duplicate. * Indicates a significant difference 
as determined by the Student's t-test, with p-values of <0.05. 
To investigate the role of the NS1 protein of avian influenza A viruses against 
the induction of the AP-1 promoter, the expression vectors for allele A and B 
NS1 proteins of both subtypes of influenza A viruses were co-transfected with 
pAP-1-Luc  reporter  plasmids  into  A549  cells,  and  subjected  to  dsRNA 
stimulation  before  lysis  for  measurement  of  luciferase  activity.  The  results 
showed that the activation of the AP-1 promoter was significantly inhibited by 
the expression of allele A NS1 proteins from both subtypes (~52%) (p<0.05) 
(Figure 17). The allele B NS1 proteins of corresponding subtypes were unable 
to  inhibit  this  exogenously  administered  dsRNA-induced  AP-1  promoter 
activity,  although  a  low-level  (statistically  non-significant)  reduction  was 
obvious (H6N8-B=8% and H4N6-B=14%).   64 
At this point, the results from the reporter assay demonstrated that the allele 
A NS1 protein inhibits the AP-1 and NF-κB transcription factors by interfering 
in the signal transduction pathways that lead to activation of AP-1 and NF-κB 
promoter activity, respectively. In contrast, the allele B NS1 proteins from the 
corresponding influenza A subtypes were weaker in this inhibition and hence 
only weakly interfered in the signaling pathways. The same trend was observed 
when the experiment was repeated in MiLu cells. These results demonstrated 
that  differential  regulation  of  IFN-β  production  by  alleles  A  and  B  was 
mediated through all three transcription factors, and further confirmed that NF-
κB and AP-1 are important regulators of IFN-β. However, the individual and 
cumulative effects of these IFN-β regulators, in term of influenza infection, 
remain to be investigated. 
Next,  the  structural  basis  of  the  inhibition  of  the  NF-κB  and  AP-1 
promoters was investigated. The results showed that the RNA binding domain 
from neither allele A nor B supported NF-κB and AP-1 promoter inhibition, 
being non-significant when compared to positive control. On the contrary, the 
effector domain from both alleles A and B led to a significant suppression of 
NF-κB and AP-1 promoter activation (p<0.05). In MiLu cells, a similar pattern 
was experienced. To further confirm this characteristic of RBD and ED, two 
previously described chimeric NS1s were used, containing either the RNA binding 
domain of allele A and the effector domain of allele B (H6N8 chiNS1 A/B) or vice 
versa (H6N8 chiNS1 B/A). Interestingly, NF-κB and AP-1 promoter inhibition was 
reversed in both chimeric NS1s, and was comparable to their wildtype (wt). This 
ability of chimeric NS1 was reproducible in MiLu cells, and was non-significant 
when  compared  to  corresponding  wt  NS1  protein.  Taken  together,  these  data 
demonstrated that the two domains are probably functionally interactive in a co-
operative manner to result in their overall NF-κB and AP-1 promoter inhibition. 
The conclusion that the ability to block dsRNA-induced NF-κB and AP-1 
signaling  is  mapped  into  the  effector  domain,  and  that  the  RNA  binding 
domain alone is unable to block NF-κB and AP-1 promoter activity in both 
A549 and MiLu cells, confirms our previous study (Paper II). It has already 
been demonstrated that  the effector domain of the NS1 protein is  not only 
involved in regulation of cellular activities by protein-protein interactions but 
also essential for the dimerization and stability of RNA domain (Hale et al., 
2008c; Kochs et al., 2007; Donelan et al., 2003; Wang et al., 2002). Consistent 
with  these  results,  it  is  likely  that  the  lack  of  effector  domain  in  the  NS1 
protein influences the three-dimensional structure and dimerization of the RNA 
domain,  which  affects  the  function  in  the  suppression  of  NF-κB  and  AP-1 
promoter activation. Moreover, it should be noted that within the RNA binding   65 
domain, a unique motif of eight continuous amino acids might have biological 
relevance, which warrants further investigation by mutagenesis studies. 
4.3  Contribution  of  HPAIV  H5N1-like  NS1  protein  to  the 
pathogenicity of a recombinant H9N2 influenza virus (Paper 
V) 
A  great  wealth  of  earlier  reports  and  our  comprehensive  studies  have 
demonstrated that the NS1 protein regulates a plethora of cellular activities. 
Among them, the NS1 protein plays an indispensible role in antagonizing the 
host IFN system. Therefore, it is plausible to speculate that low pathogenic 
avian influenza viruses (LPAIV) may use this protein as a shield to be able to 
escape the host immune response. In this regard, it has been demonstrated that 
reassortant H9N2 viruses (LPAIV) acquire genotypic characteristics of highly 
pathogenic H5N1 influenza A viruses (Iqbal et al., 2009). In an attempt to 
screen  backyard  poultry  for  pathogens,  a  H9N2  virus 
(A/Chicken/Pakistan/BYP/2010)  was  isolated  and  analyzed  genetically  and 
biologically. The phylogenetic analysis, based on the hemagglutinin (HA) and 
neuraminidase (NA) genes showed that this isolate belongs to the G1 group of 
H9N2 influenza A viruses, whereas based on non-structural (NS) gene segment 
it clusters into a clade 2.2 with highly pathogenic H5N1 of Z-genotype. Based 
on this interesting outcome, and results demonstrated previously (Geiss et al., 
2002; Basler et al., 2001), it is tempting to hypothesize that reassortant viruses 
of  subtype  H9N2  have  acquired  enhanced  pathogenicity,  replication  and 
transmission  abilities  due  to  recruitment  of  a  new  NS1.  Among  others,  as 
described before, inhibition of IFN-β is one of the best-characterized strategies 
of NS1 protein primarily for increased virulence and host range determination 
(Hale et al., 2008c; Li et al., 2006b). Therefore, we attempted to screen NS1 
proteins of H9N2 (H9N2/NS1) and HPAIV H5N1 (H5N1/NS1) in parallel for 
their  abilities  to  regulate  different  signaling  pathways,  and  investigated  the 
molecular mechanisms in IFN-β production in human and avian cells. 
The combined activity of three transcription factors (IRF3, NF-κB and AP-
1) is essential to initiate the transcription of IFN-β (Maniatis et al., 1998). To 
evade  such  a  response,  the  NS1  protein  has  evolved  to  inhibit  all  of these 
central activators of type I IFN (Hale et al., 2008c). However, little is known 
about how the NS1 protein of recombinant H9N2 performs such maneuvers. 
Initially,  the  role  of  the  NS1  protein  of  H9N2/NS1  and  H5N1/NS1  was 
evaluated to resolve this question using 4xIRF3, pAP-1-Luc and pNF-κB-Luc 
reporter  plasmids,  which  are  under  the  control  of  IRF3,  AP-1  and  NF-κB 
promoters,  respectively  (Table  2).  The  results  demonstrated  that  both  NS1   66 
proteins of H9N2 and H5N1 are equally potent in blocking dsRNA-induced 
IRF3 (Figure 18 A, D), AP-1 promoters  (Figure 18 B, E) and TNF-α induced 
NF-κB promoter (Figure 18 C, F). Therefore, I conclude that the understudy 
NS1  protein  of  H9N2  viruses  has  strong  abilities  to  down-regulate  IFN-β 
production from all major possible ways  when compared to HPAIV H5N1 
subtype. Further, this inhibition was found to be species independent when 
compared in human A549 and CEF cells. 
                      
Figure 18. Inhibition of dsRNA- or TNF-α induced pathways by expression of the NS1 protein of 
influenza A viruses. A549 and CEF cells were co-transfected with the expression plasmids for 
NS1 protein derived from H9N2 (H9N2/NS1) and H5N1 (H5N1/NS1) with 10 ng of pGL4.74 
together with either 4xIRF3-Luc (A,D), pAP-1-Luc (B,E) pNF-κB-Luc (C,F) reporter plasmids, 
or normalized with empty flag vector (cont.) or left untreated (cells). After a 24 hours post-
transfection incubation period, the A549 cells were either stimulated with 10 µg of dsRNA (poly 
I:C) per ml (4xIRF3 and pAP-1) or 25 ng/ml of TNF-α (NF-κB) or left untreated (cells). After an 
additional  24  hours  of  incubation  period,  the  cell  extracts  were  prepared  and  the  luciferase 
activity was measured using the Dual-Luciferase Assay System (Promega). The values in mock-
transfected cells were normalized and were set to 100% (4xIRF3 cont., pAP-1 cont. and NF-κB 
cont.). Error bars indicate standard deviations. The data shown here are representative for three 
experiments  with  transfections  performed  in  duplicate.  *  indicates  a  significant  difference  as 
determined by the Student's t-test, with p-values of < 0.05.   67 
A substitution was observed at a functionally important site (aa position 221) 
in the C-terminus of the NS1 protein of H9N2 and H5N1 (Volmer et al., 2010). 
The sequence analysis of both NS1 proteins showed that the NS1 protein of 
H9N2 carries lysine (K) at position 221, whereas the NS1 protein of H5N1 
carries glutamic acid (E) at this position. Despite these substitutions, there was 
no difference in the function, expression and cellular localization pattern, in 
accordance with previous reports (Wang et al., 2010). However, it has been 
observed that the localization pattern of NS1 protein is different (cytoplasmic) 
during influenza A virus infection compared to transfection of NS1 constructs 
(nuclear). The nuclear localization pattern has been suggested to correlate with 
the pathogenicity of influenza A viruses (Volmer et al., 2010), and therefore it 
would be of interest to investigate the contribution of this substitution in the 
context of viral infection and replication. 
                 
Figure  19.  A  VSV-GFP  based  IFN  bioassay  to  detect  the  level  of  inhibition  of  IFN-β  gene 
expression in the presence of H9N2/NS1 and H5N1/NS1 proteins. (Left panel) The stimulation 
of IFN-β  by dsRNA is inhibited in the presence of NS1 proteins and thus leads to efficient 
replication of the VSV-GFP virus. (Right panel) A549 cells were transfected with 300 µg of 
expression  plasmids  encoding  H9N2/NS1  and  H5N1/NS1  proteins.  After  18  hours  post-
transfection incubation period, the cells were either stimulated with 5 µg of dsRNA per ml or left 
untreated (mock treated). After an additional 24 hours, the cells were infected with VSV-GFP 
(MOI of 2). Fluorescence was measured after 18 hours of infection. 
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The NS1 protein is a multifunctional protein that inhibits IFN-β production at 
multiple steps (Figure 13, introduction section) (Hale et al., 2008c; Kochs et 
al.,  2007).  Therefore,  the  whole  IFN-β  pathway  was  evaluated,  and  it  was 
observed  that  both  proteins  were  equally  potent  in  inhibiting  IFN-β 
transcription, IFN-β synthesis (Figure 19) and IFN-β signaling, terminated at 
ISRE transcription factor. All of these characteristics are well defined for the 
NS1 protein HPAIV H5N1, suggesting a strong functional homology between 
the  NS1  protein  of  H9N2  and  H5N1.  Furthermore,  NS1  protein  has  been 
identified  to  inhibit  nuclear  localization  of  IRF3,  as  another  strategy  to 
abrogate  IFN  mRNA  transcription  (Talon  et  al.,  2000).  Consistent  with 
previous  reports,  it  was  found  that  both  NS1  variants  inhibited  the  nuclear 
localization of IRF3 transcription factor.  
The NS1 protein of HPAIV H5N1 possessed a five amino acid deletion in 
the  middle  of  the  C-terminus,  and  it  is  believed  that  this  deletion  started 
appearing after the year of 2000 (Dundon & Capua, 2009). The last report of 
H5N1  NS1  protein  without  the  five  amino  acid  deletion  appeared  from 
Kazakhstan  in  2006  (GenBank  accession  number  ACJ53834)  (Dundon  & 
Capua,  2009).  Although  the  biological  significance  of  this  deletion  is  ill 
defined, it was reported that H5N1 influenza A viruses with the deletion in the 
NS1 protein were more pathogenic than H5N1 without the deletion, in both 
chickens  and  mice  (Long  et  al.,  2008).  Also,  it  is  now  clear  that  the  NS1 
protein is an essential virulence factor for avian influenza A viruses in other 
hosts, and may serve as a fundamental marker for the pathogenicity (Ma et al., 
2010; Wang et al., 2010; Li et al., 2006b). Therefore, it is logical to think that 
H9N2 influenza A viruses adapt the  NS gene segment from H5N1 to  take 
advantage of this virulence factor. Moreover, it is obvious from the results 
demonstrated in this study that NS1 proteins of H9N2 and H5N1 have strong 
genetic  and  functional  similarities.  These  characters  may  facilitate  the 
increased  virulence  and  pathogenicity  in  H9N2  virus  infections.  Therefore, 
these viruses should not be overlooked when investigating their epizootic and 
zoonotic potential. 
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5  Conclusions 
Based on these findings, it was possible to demonstrate that the NS1 protein, in 
a manner dependent on alleles, applies multiple mechanisms for manipulating 
the IFN signaling pathway, as measured by ISRE, NF-κB and AP-1 promoter 
activation, IFN-β mRNA transcription and IFN-β protein expression. 
 
Specifically, the following conclusions can be drawn out from these studies: 
 
ﾧ  Despite the fact that the NS1 protein is a well-characterized virulence 
factor, the IFN antagonistic activity is attributed only to allele A NS1 
proteins, whereas allele B is inert in this matter. 
ﾧ  This study provided insights showing that allele A and B NS1 proteins 
can differentially regulate the host NF-κB signaling pathway, which 
may offer some new perspectives on understanding the host regulation 
of viral RNA synthesis, especially when allele B is shown to facilitate 
viral replication. 
ﾧ  Based  on  the  failure  to  inhibit  AP-1  activation  by  allele  B,  it  is 
presumed that the NS1 protein is likely to exert a similar effect in 
preventing  the  activation  of  NF-κB,  which  subsequently  results  in 
overall inhibition of IFN-β. 
ﾧ  Structural insights showed that inhibitory activities for ISRE, NF-κB 
and  AP-1  promoters,  and  subsequently  IFN-β  inhibition,  could  be 
mapped to the C-terminal effector domain. 
ﾧ  Further evidence was provided that well matched ED and RBD are 
crucial  for  dsRNA-induced  ISRE  promoter  activities,  whereas  ED 
alone,  independent  of  RBD  nature,  is  sufficient  for  interaction  and 
prevention of the NF-κB and AP-1 promoter activities. 
ﾧ  It has become apparent that, as a result of co-circulation of different 
subtypes  of  influenza  A  viruses  in  the  same  host,  LPAIV  have   70 
acquired gene products of HPAIV. This capability allows the viruses 
to replicate in a hostile environment by efficiently antagonizing the 
induction of antiviral mechanism mediated by type I IFN systems.   71 
6  Future prospects 
Although our knowledge about how the NS1 protein of influenza A viruses 
interferes in the IFN signaling pathways has increased significantly in recent 
years,  there  are  several  elements of  this  complicated  phenomenon  that  still 
need  to  be  resolved.  It  is  undoubtedly  essential  to  understand  the  precise 
molecular mechanisms underlying the versatile nature of NS1 proteins, and to 
determine the biological implications of allele A and B NS1 proteins in viral 
pathogenicity, virulence and host determination, especially in the worst-case 
scenario  when  most  of  the  previously  characterized  residues  are  identical 
between both alleles of the NS1 protein. 
It remains to address the factors that determine the selection of allele A or 
allele B NS gene segments in the same subtype of influenza A viruses, in the 
same bird population and in the same geographical region. Above all, such 
selection has been observed during the same period of time. It is likely that the 
evolutionary process for the NS gene is as complex interplay as that of HA and 
NA evolution. However, comparison of both of these influenza elements may 
provide genetic linkage between the selections of either gene. As has been 
predicted for HA and NA genes, a steady frequency of reassortment over a 
certain period of time may elevate fitness of specific HA-NA combinations; 
and it is likely that such a phenomenon exists for NS gene segments, and may 
explain the evolutionary dynamics in their natural wild bird hosts. However, it 
can be speculated that AIV exists in a large pool of transient and functionally 
equivalent  gene  segments,  and  that  providing  a  complex  pattern  of  host 
immunity results in successive changes in each allele, primarily to intricate 
fitness for survival which would be harmonious with the virus's divergence 
under  sympatry.  Such  an  hypothesis  has  been  employed  for  several  HA 
subtypes of influenza A viruses, such as H14 that exists only in Russia, and 
H16 that has been isolated only from gulls. This restriction is linked to existing 
immunity  against  a  specific  subtype.  Therefore,  research  into  the  factors   72 
responsible for allele selection will help to better understand the evolution and 
ecology of influenza A viruses, and may help to generate a novel model of 
cell-tropism and host adaptation. 
The  stable  adaptation  of  AIV  to  several  novel  hosts  (horses,  swine  and 
humans), within which transmission is frequent, has largely been studied. This 
adaptation  is  mainly  associated  with  acquisition  of  mutations  that  make  an 
individual virus distinct from the rest of the viral population. Provided that 
adaptation of AIV to novel hosts restricts its return back to avian hosts, mainly 
due to the genetic constellations in the new host (Dugan et al., 2008; Swayne, 
2007), it is likely that adaptability of allele A to allele B may be responsible for 
the  low  overall  prevalence  of  allele  B  containing  influenza  A  viruses,  and 
therefore limit (with two exceptions) their presence in avian species.  
Given that the production of type I IFNs  is directly associated with the 
replication and attenuation of influenza A viruses (Geiss et al., 2002; Basler et 
al., 2001), weak ability of the allele B NS1 protein to abrogate IFN production 
can be exploited for the host's benefit. A selection of strains carrying the allele 
B NS gene segment may result in optimal inhibition of IFN production, which 
allows the replication of viruses to the extent of efficient immunogenicity but 
not  sufficient  to  cause  disease.  Alternatively,  such  a  suggestion  can  be 
employed  using  suitably  truncated  and  mutated  NS1  protein,  which  would 
allow the viruses to be attenuated and lead to establishment of a live attenuated 
vaccine. 
It is difficult to study all of the roles of the NS1 protein entirely in cell-
culture systems (in vitro), and such studies might not be a true image of the 
biological nature of this multifunctional and complicated protein. Therefore, it 
is  essential  to  use  suitable  and  relevant  animal  models  (in  vivo),  to  better 
understand the role of allele A and B NS1 proteins in influenza A viruses’ 
pathogenicity, host-adaptation, cell-tropism and virulence in the context of live 
virus infection. 
There is a wealth of reports describing not only the multi-functionality of 
the  NS1  proteins  in  abrogating  IFN  responses,  but  also  numerous  other 
functions in the regulation of host-cell mechanisms. However, the majority of 
these reports describe only single functions at the same time. Therefore, it is of 
great importance to rule out whether NS1 can interact with a single cellular 
partner  or  regulate  multiple  partners  at  the  same  time.  Such  studies  are 
essential to highlight the priorities of the NS1 protein during the course of 
influenza A virus pathogenesis, so that possibilities to target specific functions 
of  NS1  protein  will  be  evaluated.  Moreover,  using  established  models 
characterized for the functionality of NS1 protein, it is possible to incorporate 
allele A and B NS1 proteins, to cumulatively understand the implication of   73 
allele division in the pathogenesis and replication of influenza A viruses, apart 
from their obvious role in regulation of IFN-β production. This might further 
be  required  to  unanimously  resolve  the  complex  interplay  between  the 
multifunctional NS1 protein and the hostile cellular environment.  
It  has  been  reported  that  inhibition  of  the  NF-κB  pathway  blocks  the 
replication of influenza A viruses in otherwise susceptible cells (Nimmerjahn 
et al., 2004). This indicates that an intact NF-κB pathway is a pre-requisite for 
efficient  viral  infection.  To  further  address  the  underlying  molecular 
mechanism,  it  was  revealed  that  NF-κB  regulates  viral  RNA  synthesis  and 
hence facilitates its replication (Kumar et al., 2008). The NS1 protein, on the 
other hand, blocks the activation of the NF-κB pathway, presumably to prevent 
an over-expression of IFN-β (Wang et al., 2000). Given that allele B does not 
completely block NF-κB and an intact NF-κB is required for influenza viral 
replication, it is hypothetically possible that increased replication of influenza 
A viruses in the presence of the allele B NS segment might be due to active 
NF-κB. In favor of this, it is noted that influenza A viruses with a NS segment 
of allele B type have a tendency to replicate efficiently compared to their naïve 
or recombinant forms (carrying allele A NS1 or delNS1) (van Wielink et al., 
2011;  Wang  et  al.,  2010).  Therefore,  a  molecular  understanding  of  this 
phenomenon may lead to a better understanding of host regulation of viral 
RNA  synthesis,  and  may  establish  the  basis  for  therapeutic  approaches  to 
combat influenza infection. 
In  conclusion,  despite  significant  advancements,  several  fundamental 
questions about the dynamics of NS1 protein functionality, in particular the 
contribution of the alleles dimension, remain to be addressed. Moreover, the 
properties  of  alleles  A  and  B  AIV  in  viral  infectivity,  pathogenicity,  host 
adaptabilities  and  viral  pathogenesis  are  poorly  understood,  and  therefore 
warrant further investigations.   74 
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7  Populärvetenskaplig sammanfattning 
	 ﾠ
Interferoner är små äggviteämnen (proteiner), vilka är naturligt förekommande 
i kroppen som utgör en första försvarslinje mot virus eller vissa bakterier, och 
produceras även i närvaro av immunstimulerande faktorer. I människokroppen 
produceras tre familjer av interferoner. De interferoner som är av intresse för 
oss är typ I interferoner; interferon-alfa från vita blodkroppar, interferon-beta 
från fibroblaster samt typ II interferoner så kallade interferon-gamma från en 
särskild vit blodkropp som kallas lymfocyt. Typ I interferoner har också en rad 
effekter på celler i immunsystemet. Det är känt sedan tidigare att interferoner 
kan  förstärka  immunsvaret  mot  proteiner,  men  det  är  osäkert  vilken  roll 
interferoner  spelar  för  uppkomsten  av  adaptivt  immunsvar  under 
virusinfektion. 
Alla  angripande  virus  är  mer  eller  mindre  känsliga  för  interferoner. 
Interferonerna bildas mycket tidigt i en infektion, ofta inom loppet av några 
timmar efter virusets första framträdande och kan påverka virusets förmåga att 
föröka  sig  inuti  cellen.  Därför  är  det  viktig  för  ett  angripande  virus  att  ha 
resurser att kunna ”ta hand om” värddjurets interferonsvar. Influensavirus är 
inget  undantag.  Man  har  på  senare  tid  identifierat  ett  virusprotein,  icke-
strukturellt protein (non-structural protein) 1 (NS1) som en av de faktorer som 
är viktiga för att påverka värdens immunsvar.  
I  våra  studier  har  vi  fokuserat  på  förmågan  hos  NS1  att  nedreglera 
värdcellens immunsvar. Vår huvudhypotes är att NS1 har utvecklats för att “ta 
hand om” den värd? som influensavirus lever i.  
När vi tidigare har tittat på den genetiska variation som finns hos olika 
influensavirus, visar det sig att variationen är ganska begränsad. Vi fann dock 
virus som har en genvariant av NS1, som kallas allel A, och virus som har en 
annan genvariant kallat allel B. Av dessa hittas allel A hos influensavirus som 
infekterar olika däggdjur (människa, gris och häst), medan allel B i princip 
uteslutande hittas hos influensavirus som infekterar fåglar. Majoriteten av de   76 
virus vi studerade hade NS1 av varianten allel A (87 %) och enbart 13 % hade 
allel B. Denna uppdelning är helt baserat på genetisk karaktärisering och deras 
funktionella konsekvenser är till stor del okända. I den här studien har vi därför 
försökt att bringa insikter om strukturella och funktionella skillnader som kan 
finnas mellan dessa två genvarianter av NS1. 
För  att  kunna  studera  på  vilka  sätt  de  två  varianterna  av  NS1  påverkar 
värdens immunsvar har vi satt upp olika cellkultursystem. Vi använder oss av 
plasmider  (gen-kassetter)  som  uttrycker  de  olika  NS1-proteinerna.  Dessa 
plasmider introduceras i cellerna tillsammans med olika reporterplasmider, för 
att  kunna  mäta  nedreglering  av  immunassocierade  gener.  På  så  sätt  kan  vi 
jämföra de olika NS1-genernas förmåga att nedreglera t ex interferon, som är 
en mycket viktig virusbekämpande molekyl, i celler från olika värddjur. 
Våra resultat visar att NS1 av allel A har en starkare förmåga att hämma 
produktionen av interferon-beta i humana celler, jämfört med NS1 av typen 
allel B från motsvarande influensasubtyper. Vi kunde bekräfta detta genom att 
studera hur dessa proteiner kan hämma aktiveringen av flera cellulära faktorer 
som är av stor betydelse för immunsvaret (ISRE, IRF3, NF-κB, AP-1, samt 
interferon-beta på mRNA- och proteinnivå).  
Det har tidigare observerats att virus med olika varianter av NS1 visar en 
varierad grad av sjukdomsframkallande förmåga hos minkar (Mustela vison). 
Vi  undersökte  material  från  tidigare  infektionsstudier  på  mink  där 
influensavirus  som  bar  på  NS1  av  allel  A  verkade  vara  mer 
sjukdomsframkallande än virus med NS1 av allel B. En fråga som vi ställde 
oss var om det fanns strukturella skillnader mellan de två NS1-varianterna. 
Våra  studier  tyder  på  att  interaktion  mellan  NS1  och  olika  cellulära 
komponenter förmedlas av det som kallas effektordomänen på proteinets C-
terminal. 
Sammantaget visar våra studier på den mångsidiga natur och återbekräftar 
den oumbärliga roll som NS1-proteinet spelar för influensavirus.   77 
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